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Abstract
The generation of reactive oxygen species (ROS) is an unavoidable background pro-
cess during a normal functioning of a cell. However, when incompletely-reduced oxy-
gen species are generated in excess, they can oxidize a variety of organic molecules,
cause a mitochondrial dysfunction and initiate a positive feedback loop leading to
the generation of even more active ROS. To prevent an oxidative stress a healthy
cell manages the ROS concentration by means of the antioxidants regulation as well
as the removal of impaired mitochondria (mitoptosis). The ROS management is a
crucial process for a cell survival and it is controlled by a ROS-induced signaling
network, which includes different proteins bound by rather complicated cross-talks.
This is a good example of a nonlinear multidimensional system, which is too complex
for an intuitive understanding and needs a more advanced system approach. Indeed,
the ROS concentration and the mitochondrial potential are system properties of a
whole cell and they depend on thousands of macromolecular interactions.
One of the goals of a system approach is to understand how a biological function
emerges from a system as a whole, while it can not emerge from a single component
of a system. This is closely related with the design principle studies – the research
that helps to identify how certain components (subsystems, species, pathways) are
responsible for a certain biological behavior of a system. Adding module by module
(the domino approach [1]) one can analyze their functional role and verify how new
properties appear.
In the current thesis the model of the ROS management network is built using
the domino principle. The model offers insight into the design principles underlying
ii
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the ROS management network and enlightens its functionality in the diseases such
as cancer and Parkinson’s disease (PD). It is validated using experimental data.
The model is used for in silico study of the ROS management dynamics under
the stress conditions (oxidative stress). This highlights the phenomena of both
adaptation to stress and the stress accumulation effect in case of repeated stress.
This study also helps to discover the potential ways to a personalized treat-
ment of the insufficient ROS management. The different ways of a control of the
ROS management network are shown using the optimal control approach. Obtained
results could be used for a seeking of the treatment strategies to fix the ROS man-
agement failures caused by an oxidative stress, neurodegenerative diseases, etc. Or,
in vice versa, to develop the ways of a controllable cell death that might be used in
cancer research.
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Chapter 1
Introduction
1.1 Reactive oxygen species
1.1.1 Creation and transformation of reactive oxygen species
ROS are the natural byproduct of a vital cell activity. They might be produced in
the cytoplasm during the redox reactions (e.g. Fenton reaction [2]). Alternatively,
the ROS can be released from other cell organelles, such as the endoplasmic reticu-
lum (ER) [3], and as a result of some enzymatic and non-enzymatic reactions [4, 5].
The main internal cell supplier of the ROS is the mitochondrion – a cell organelle
that is responsible for the energy production by means of the Electron Transport
Chain (ETC). The reactive nitrogen species [6] might also take part in the ROS
formation.
At the same time the intracellular ROS can be generated by a number of external
sources. For example, as a result of a smoking or a chemical exposure (e.g., paraquat,
herbicides, phenols) [7, 8]. The ROS could be generated after an ionization of water
molecules by X- or γ-rays as well as after the ultra-violet light exposure of the
peroxide H2O2 [9]. Some anti-tumor drugs and antibiotics activate an excessive
generation of the ROS to provoke a diseased cell death via apoptosis [10, 11].
From the chemical point of view, typical ROS are the active compounds that
contain oxygen [12, 13] and have one unpaired electron in the outer orbit (i.e., free
1
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radicals). The most common ROS are the peroxide (H2O2), the superoxide (
•O2−)
and the hydroxyl radical (•OH) [14]. In general, a half-time of free radicals varies
from milli- to nanoseconds that makes them short-living substances. At the same
time, the free radicals are produced inside a cell in a regular or “on demand” manner
creating a certain amount of the intracellular ROS.
The ROS production could be described by a set of chemical transformations.
During the first step the reduction of the molecular oxygen takes place and the
superoxide (•O2−) is produced:
O2 + e
− → •O2−.
Then the dismutation of superoxide produces hydrogen peroxide (H2O2):
2 H+ + •O2− + •O2− → H2O2 + O2.
At the last step hydrogen peroxide could be completely reduced to water or partially
reduced to the hydroxil radical (•OH):
H2O2 + H2O2 → 2 H2O + O2
or
H2O2 → OH• + •OH.
All common types of the ROS [15] are grouped in the Table 1.1.
1.1.2 Redox potential
Any chemical species in a cell has its own redox potential (electronegativity). It is a
measure of the affinity of a substance for electrons in comparison with hydrogen for
which the value of the redox potential is set to be 0 V. The substances that are more
electronegative than hydrogen have a positive value of the redox potential and vice
versa. The greater the difference between the redox potentials of two substances
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ROS Short description
•O2−, superoxide anion A product of the one-electron reduction of oxy-
gen. The superoxide is a quite toxic species and
it is used by the immune system to kill danger
microorganisms. At the same time it participates
in the development of many diseases and the ag-
ing [16]. Superoxide formation occurs in many re-
actions and in the ETC [17, 18]. Superoxide might
be effectively neutralized by a scavenging enzyme
superoxide dismutase (SOD).
H2O2, hydrogen peroxide Two-electron reduction state, formed by a dismu-
tation of •O2− or by a direct reduction of oxygen.
It plays an important role in the immune system.
Hydrogen peroxide might decompose into the hy-
droxil radical that can directly damage intracellu-
lar components, especially, mitochondria [19].
•OH, hydroxyl radical A highly reactive neutral form of the hydroxide
ion [20]. It is extremely reactive and attacks most
cellular components.
ROOH,
organic hydroperoxide
Formed in the reactions with cellular compo-
nents (e.g. lipids) [15].
RO•, alkoxy and ROO•,
peroxy radicals
Produced in the presence of oxygen and participate
in lipid peroxidation reactions. It may induce a
damage in lipophilic compartments [21].
HOCl, hypochlorous acid Formed from peroxide. It performs both pro-
inflammatory and anti-inflammatory functions.
However, it has a high reactivity and may oxidize
protein constituents [22].
ONOO−, peroxynitrite Interacts with lipids, DNA, and proteins. The per-
oxynitrite generation is a crucial pathogenic mech-
anism [23].
Table 1.1: Common reactive oxygen species and their short description.
the easier an electron can travel from the less electronegative substance to the more
electronegative one. As a result a donor of an electron becomes oxidized.
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If there is an oxidized form (Aox) of some substance A, then to obtain a reduced
form Ared the following reaction should take place:
Aox + ne
− ↔ Ared, (1.1)
where n electrons are taken from a donor.
The redox potential difference ∆E between a donor and an acceptor of the
electron is related to the associated Gibbs free energy change ∆G:
∆G = nF∆E, (1.2)
where n is a number of transferred electrons and F = 96485 J
mol·V is Faraday’s con-
stant. The Gibbs free energy is the energy that is available to do a work. If a
reaction reduces the overall Gibbs energy of a system (∆G < 0), then it is referred
to a thermodynamically spontaneous reaction (favoured reaction). Using tabulated
values of the redox potential for different substances inside a cell it is possible to
understand a direction for an electron transfer. The typical values of the redox po-
tential of the intracellular elements vary from −0.7 V to +0.8 V [24]. The values of
the redox potential for typical ROS are in the range from +1 V to +2.3 V [25]. It
means that the value of ∆E for the pair donor-acceptor is negative that guarantees
the negativity of Gibbs free energy ∆G. Thus, the reaction of oxidation of the in-
tracellular components is favourable from thermodynamical point of view, therefore
the ROS may easily oxidize them.
1.1.3 Electron transport chain
The main function of the mitochondrion is to generate energy that is stored in
the molecules of adenosine triphosphate (ATP). To do that the mitochondrion uses
the electron transport chain (ETC) [26]. The ETC includes several spatially dis-
tributed redox reactions to facilitate an electron transfer between a donor and an
acceptor (see Fig. 1.1).
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Figure 1.1: The electron transport chain (ETC) is used to create a
channel for proton transfer. Protons are an important component in the
process of ATP generation. The complex I accepts the electrons from
NADH, and passes them to the coenzyme Q (ubiquinone) that also receives
the electrons from the complex II (succinate dehydrogenase). Then the
electrons are transferred into the complex III (cytochrome bc1 complex)
and complex IV via cytochrome C (cyt C). Finally, in the complex IV the
electrons are used for the reduction of the molecular oxygen to water.
The process starts at the inner membrane of the mitochondrion. Here the re-
duced forms of coenzyme nicotinamide adenine dinucleotide (NADH) and redox
cofactor flavin adenine dinucleotide (FADH) are used as the donors of electrons.
The electrons are passed via a transport chain and take part in the reduction of
oxygen into water. The electron transfer is carried out from a donor to a more elec-
tronegative acceptor and repeated until the electron reaches oxygen. The transfer
releases the energy that is used to pump the protons from the mitochondrial matrix
into the intermembrane space. At the end ATP synthase uses the flow of protons to
generate ATP from adenosine diphosphate (ADP).
In a normal cell about 0.1-2% of the electrons are not able to finish the transfer
chain and leave the ETC to take part in the formation of active radicals [27]. How-
ever, the increase of the ROS concentration promotes electrons to escape from the
ETC. As a result, ATP generation is reduced that negatively affects a cell.
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1.1.4 Useful functions of the ROS
The ROS are often considered as the danger species that might damage cell compo-
nents. However, the ROS also have the useful functions listed below.
 A killing of invading pathogens [28, 29, 30].
 The intracellular signalling [31, 32].
 A taking part in physiological reactions such as the immune response [33] and
the mobilization of the ion transport system. For example, blood cells in the
place of an injury start producing the ROS to activate the process of the wound
healing.
 The regulation of a stem cell differentiation [34]. The experimental research
with different stem cell lines, such as Hematopoietic Stem Cells (HSC) [35,
36], Bone Marrow Stem Cells (MSCs) [37] and neural stem cells (NSCs) [38]
show the following tendency: the low ROS level correlates with quiescent cells,
the medium ROS level – with active differentiating/proliferating cells and high
ROS level with senescent cells. The regulatory role of the ROS might be used
by cells for a kind of quorum sensing in the context of the whole body.
 The triggering of a programmed cell death (apoptosis) [39]. In contrast to
necrosis of a cell (traumatic death), apoptosis is a well controlled process.
It consists of a sequence of biochemical events that change a cell structure
and cause its death. Unlike necrosis, the species produced by the apoptosis
are quickly removed by phagocytic cells and do not pose a threat to a cell
environment.
1.1.5 Cellular mechanisms for the ROS management
The ROS concentration depends on a cell functioning. For example, quiescent
cells [40] have less number of mitochondria and a low metabolic activity. Their
main function is to maintain themselves and to be the most protective ones. As a
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result, they have a very low ROS level. Active cells have a higher metabolic load
and consequently generate more ROS. A good example is dopaminergic neurons
that need a lot of energy to secrete dopamine. When a cell grows older and becomes
more damaged, the ROS level naturally grows further.
There are also some other factors that manipulate the ROS concentration. For
example, the ROS level is highly affected by a physiological state, e.g., by anoxia.
Also, the ROS level is shown to be higher when cells are at the lower cell density [41].
It might mean that a body needs to increase the proliferation and differentiation
of stem cells. The ROS level would be then an easy affordable signal for a cell to
monitor how many other cells are around.
Normally, a cell has two mechanisms to control the ROS concentration: enzy-
matic and nonenzymatic. The first found enzymatic system was the superoxide
dismutase (SOD) [42, 43], which regulates the superoxide anions concentration by
converting them into the peroxide:
2 O2
− + 2 H+ → H2O2 + O2
and then into water with a participation of the enzyme catalase:
H2O2 → 2 H2O + O2.
Another enzymatic system is the glutathione that catalyzes the degradation of per-
oxides (hydrogen and organic ones) into the alcohols. The examples of the nonen-
zymatic antioxydants are vitamin C and vitamin E [8].
If the antioxydants fail, a removal of impaired mitochondria might be star-
ted [44, 45]. The process of mitochondria removal is called mitophagy and might
be initiated by several processes [46, 47, 48]. Alternatively, mitochondria might be
recovered via the mitochondrial-derived vesicles (MDV)[49]).
The precise ROS management is a critical component for a cell survival. Roughly
speaking, the ROS concentration might be regulated via antioxidants activity but
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overall regulatory network is rather complicated and has other components apart
from antioxidants, e.g. the proteins Nrf2, Keap1, Parkin, p62, DJ-1.
Disruptions in the ROS management might be involved in the development of
many diseases. Thus, a cancer cell may deal with higher ROS concentrations and is
more protected against the oxidative stress. On the contrary, in neurodegenerative
diseases (Alzheimer, Parkinson, Huntington) the ROS regulation network might be
disrupted and promote the death of neurons.
1.1.6 Oxidative stress
The most dangerous part of the oxidative stress is the start of an excessive genera-
tion of the ROS. Normally, the intracellular ROS concentration is low and a cell can
perform a deactivation of the excessive ROS using antioxidants or just by replacing
impaired mitochondria. A significant increase of the ROS concentration inside a
cell may provoke an oxidative damage of a cell structures including DNA, proteins,
and lipids causing different types of a cell dysfunction. For example, a damage of
mitochondrial lipids could disrupt mitochondria functioning. In its turn, a mito-
chondrial dysfunction initiates a positive feedback loop and leads to the generation
of even more active ROS.
In case of a nonreversible oxidative stress a cell might die because of either
apoptosis or necrosis. In case of apoptosis an internal cell medium manages to
degrade into non-toxic components, while during necrosis, a cell membrane is broken
and a toxic cell content escapes to the environment and may damage other cells and
tissues.
In humans an oxidative stress is a key component of many serious diseases includ-
ing cancer [50], neurodegenerative diseases [51], heart failure [52], diabetes [53, 54]
and others [55].
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1.2 ROS and neurodegenerative diseases
Parkinson’s disease (PD) is the second most widespread neurodegenerative disease,
affecting 1−3% of the population over 65 years old. The pathophysiology of neurode-
generative diseases is still hardly understood. For example, many investigations and
publications in the area relate rather to the description of pathological consequences
taking place after the disease has been developed, than to seek the explanation of
the mechanisms of the disease development. Also, very limited ways of the treat-
ment strategies are suggested: most approaches are oriented only for a maintaining
of the current patient state to delay worsening.
Sometimes, the main reason of PD development is perceived as a consequence
of a single mutation, for example, in the ubiquitin E3 ligase parkin [56]. However,
PD is an example of multifactorial systems biological disease and can involve many
processes:
 genetic predisposition, there are many genes associated with PD and their
number is continuously growing [57];
 the accumulation of protein filaments in Lewy bodies [58], complexes of hy-
perphosphorylated tau protein [59, 60], alfa-synuclein [61];
 the inflammation [62];
 the degradation of the interactions with neighboring cells (neurons and glial
cells in PD) [63];
 environmental and nutrition factors, for example, there is a positive correlation
between PD and the exposure to pesticides [64].
These processes might be in a close connection with the ROS concentration
and its dynamics. For example, the excessive ROS concentration might initiate
the accumulation of alfa-synuclein, disrupting the generation of the protein p62.
The lack of the functional p62 affects the mitophagy and may increase the ROS
concentration.
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1.3 Systems Biology
Systems biology is a science that aims to understand how a biological system works
when it is not a standalone object and is interacting with other systems and an
environment [65, 66]. Generally, to explain the functional properties of a biological
system it is necessary to take into account corresponding components and their
interaction with an environment. This might be possible with the use of a computer
model and has become one of the goals of systems biology.
Systems biology can be defined as a science that aims to understand how bio-
logical function that is absent from macromolecules in isolation emerges when these
macromolecules exist as components of a system [65].
On the one hand, biological systems consists of great number of diverse compo-
nents, and, on the other hand, the way how components interact is affected by many
other components of a system. Component properties are highly state-dependent –
local interaction between components is affected by the state of the whole system.
Systems biology proposes the solution to deal with the challenge. The information
about component’s state dependency (how components are related in a system)
may be described in the terms of mathematical equations. When equations are in-
tegrated into a mathematical model, the emergence of a biological function may be
reconstruct in silico. This may lead to principally new type of data-intensive science
and, in fact, represents a shift in the way how we conceptualize and understand
biological systems. For example, while running computer simulation it is possible to
identify how particular design feature (e.g. a certain pattern of interactions between
systems components) is responsible for systems functioning and thus one may be
able to discover design principles of the system.
Since biological systems are not standalone object, one should also consider the
interaction of systems components with the environment [66]. In the relation to
the ROS management it is impossible to limit a model to exclusive mitochondrial
ROS metabolism and it is necessary to take into account the additional processes.
For example, the ROS production in the cytoplasm in iron-catalysed reactions, the
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exchange of reductive potential between ROS and NOS (nitrogen oxide species), the
effect of the ROS on various intracellular signalling pathways, etc.
It also seems to be impossible to answer the question about the interaction of
the ROS and the mechanisms of PD if one considers the disease as a single event
with an unknown cause and certain consequences. Another approach is to consider
the disease as a systems event. It would allow to think of a disease as a shift of
homeostasis out of the normal range due to a set of perturbations in the biomolecular
network. The perception of a disease as a network perturbation [67, 68] has two
important implications; first, that there may be multiple different perturbations
that could result in a single disease phenotype. This agrees with the state-of-the-art
understanding of many complex diseases. Second, the converse argument predicts
that there could be multiple ways to return the network back to the “healthy”
state by targeting several points in the network. This provides the conceptual basis
for the action of polypharmacy, or multi-drug therapies (MDT) [69, 70] and the
development of network targeting drugs [71, 72, 73].
When speaking about systems biology, it is worth to mention a concept of syn-
thetic biology [74]. Some investigators [75] consider these two approaches as two
sides of the same coin. While systems biology applies engineering and physics prac-
tices and principles to understand and predict the behavior of a biological network,
synthetic biology can be used as a tool for systems biology to build a simpler version
of a biological system.
1.4 “Domino” approach in systems biology
The “domino” approach may facilitate an implementation of systems biology ideas
into the process of a model development [1]. The approach is based on the fact that
there are usually only a few key metabolites or proteins that interconnect different
modules in a large network. For the ROS management network the key components
is the ROS, which concentration is defined via the production and consumption
flows. Then, using in vitro enzyme kinetic assays or modular kinetic analysis [76] it
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is possible to identify how other processes depend on the ROS concentration. In this
way a first model is built with the ROS in the center and several processes around
it. This model predicts how the activation of production and consumption processes
affects the concentration of the key components and the steady-state fluxes. Dur-
ing the following steps new blocks are incorporated into the model, adding a new
functionality.
One challenge in building a domino-based model of the ROS management net-
work is related to high variability in the ROS control principles between cells, tissues,
and organisms. Individual differences might be observed both on the intracellular
level (gene expression, concentration of proteins etc.), and on the level of the emer-
gent cell behavior (membrane potential, cell mobility, etc.). In other words, every
living system is state dependent to a very high extent. One might think that it is
necessary to build a separate ROS management model for every living system and
for every particular situation. The solution could be a “blue-print” approach [65]. It
assumes that the difference (the information of state-dependence) is not in the model
topology but rather in the particular parameter sets and initial conditions. Conse-
quently, a generic “blue-print” model that can be parametrized for any particular
instantiation. Indeed, most processes and qualitative descriptions of biomolecular
interactions should be similar between those models. They would differ in rate
constants and expression levels.
1.5 Research objectives
The main research objective of this thesis is to understand the design principles of
the ROS management network and its role in PD. As a rule, biological systems have
a very complex and adaptive nature. Even a very small single-task biological net-
work could have a very specific structure including tens and hundreds of components
and interconnections and could demonstrate very complex interactions with an en-
vironment. This study proves that a systems biology approach could be successfully
implemented for the investigation of complex biological networks.
CHAPTER 1. INTRODUCTION 13
The scope of this thesis is divided into several specific objectives. The main
objective is to create a model of the ROS management network using the “domino”
principle. Starting with a very simple model of the ROS management network
it is possible to show how new features of the network emerge after adding new
subsystems. Using certain criteria, a comparison of created models is carried out to
justify the presence of particular subsystems. Finally, a validation of the model is
performed using experimental data.
A computer simulation of temporal evolution provides very limited information
about a network. Taking into account the possible application of the model to the
problem of Parkinson’s disease strategies for model control are proposed. It is well-
known that PD and other neurodegenerative diseases appear as an insufficient or
excessive generation of certain proteins. Under this condition the network leaves the
normal working mode. The idea of a control strategy is to define possible procedures
that might help to improve the state of a cell or at least maintain it on a suitable
level. These recommendations might be translated into clear practical suggestions.
The idea of system control could also be expanded beyond the field of neurode-
generative diseases. Indeed, control theory might propose a strategy to kill a cell
introducing a disbalance into the functioning of the ROS management network. Ob-
tained results might be used in cancer treatment to solve the problem of a selective
killing of cancer cells.
Finally, an idea of a very detailed model of the ROS management network is
introduced. Special attention is drawn to the problem of personalized medicine as
well as the investigation of eustress and distress phenomena.
As a conclusion, the drawbacks of the developed model and its future develop-
ment are discussed.
Chapter 2
Kinetic modeling principles
2.1 Simulation methods for biological systems
Living organisms are controlled by complex molecular networks, and a prediction of
network dynamics is a central challenge for systems biology. Very different mathe-
matical and computational methods might be applied while developing a model of
a biological system [77]. They include the boolean networks [78] or recently devel-
oped probabilistic boolean networks [79], for which the entities have discrete values
of “ON” or “OFF” representing a protein/gene being present or absent. The con-
tinuous simulation approach generally operates with the systems of ordinary (more
often – nonlinear) differential equations (ODE) [80, 81] that describe the reactions
kinetics by means of the rates and the concentrations. There are also other specific
approaches, including the stochastic simulation [82], a model development based on
partial differential equations (PDE) [83] or stoichiometric simulation [84].
The choice of the simulation method strongly depends on information about
a system to simulate. If there is comprehensive information about the elements
of a system, the pathways between them as well as about kinetic data then the
ODE-based approach might be an optimal choice. However, when a system has
an uncertain structure or when kinetic information is unavailable, the probabilistic
methods might be applied. While the discrete models bear a more intuitive charac-
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ter, the continuous models reveal detailed information of the evolution of a system,
particularly the paths lead to the attractors depending on the initial conditions and
an external stimulation.
The change of every system species concentration is expressed through the bal-
ance and the rate equations that might be represented by an ODE system. Its
solution allows simulating the kinetic behavior of a network.
Consequently, a behavior of a dynamic model is usually determined by a number
of rate constants. In case of insufficient kinetic information, the literature sources
and the specialized databases can be scanned to obtain additional data. Or the
parameters estimation procedure using experimental data might be applied [85].
The following sections contain basic description of reactions and notations used
in kinetic modelling.
2.2 Types of reactions and rate constants
2.2.1 Reactions
Reactions of synthesis and degradation
A typical reaction in the kinetic modeling [86, 87] contains a substrate and a product
and has a rate constant (or constants) defining the rate of conversion of a substrate
into a product (see Fig. 2.1).
Figure 2.1: A substrate (S) is converted into a product (P). A substrate
can represent any specie (mRNA, a protein, ROS, an antioxidant) with
some initial concentration or be just a virtual substrate with a fixed unity
concentration. The latter means that a source is either unknown or has
no importance for a model and the rate of the obtained product is defined
only by a corresponding rate constant.
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The change of the concentration of a product [P ] is defined as a multiplication
of the concentration of a substrate [S] and a corresponding rate constant k:
d[P ]
dt
= k[S]. (2.1)
As a rule, along with the generation reaction, a product has a sink reaction that
defines its degradation. Absence of such a reaction means unlimited accumulation
of a product that makes no sense from a practical point of view. The reaction of
degradation also has its own rate constant (see Fig. 2.2). However, it is possible
to consider the situation when a product has the reaction of degradation but does
not have the reaction of synthesis. For example, when some medicine is introduced
into a network by one shot, it starts an interaction with the environment and its
concentration can only decrease (reaction of degradation).
Figure 2.2: A product (P) with reactions of generation and degradation.
Each reaction has its own rate constant. In principle, a product can have
no reactions of generation and degradation. In this case it is assumed that
a product concentration remains the same during all time of simulation.
When a product has both reaction of generation and reaction of degradation its
concentration follows the difference between an input (source) and an output (sink)
flows:
d[P ]
dt
= kgen[S]− kdeg[P ], (2.2)
where [S] and [P ] are the concentrations of a source and a product correspondingly,
kgen is a rate constant for a product generation and kdeg is a rate constant for a
product degradation.
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Michaelis-Menten kinetics
The analysis of the equation (2.1) describing the synthesis of a product from a sub-
strate may raise the following question. Assuming that a rate constant is a constant,
what happens if the concentration of a substrate begins to increase? It is obvious
that the rate of the reaction will follow the change of a substrate concentration. It
may happen that the reaction rate reaches its limit defined by a catalyst (enzyme)
turnover. To avoid such scenario one can use a special type of kinetics: Michaelis-
Menten kinetics [88]. It states the dependency of the reaction rate v and a substrate
concentration [S] in the following way:
v =
d[P ]
dt
=
Vmax[S]
KM + [S]
, (2.3)
where [P ] is a concentration of a product, Vmax corresponds to the maximum rate
achieved by the reaction at a maximum saturation [S] of a substrate, KM is the
Michaelis constant that corresponds to a substrate concentration for which the re-
action rate v is 0.5Vmax (see Fig. 2.3). As a rule, a typical biochemical reaction with
only one substrate is assumed to follow Michaelis-Menten kinetics.
Substrate concentration, [S]
R
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V
max
0.5 V
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Figure 2.3: The increase of a substrate concentration [S] does not lead
to a linear increase of the reaction rate that is limited by a maximum
value Vmax.
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However, from a practical point of view usage of the kinetics law (2.3) is not
very suitable for computer models. Indeed, since a substrate [S] might change in
time then it might be included in the ODE-system describing network dynamics as
a variable. It immediately leads to a significant sophistication of the equations by
adding the fractions with variables in the denominator. Fortunately, there is a way
to avoid this problem.
If the concentration of a substrate [S] is much smaller than the value of KM (i.e.
[S] KM), then the kinetic law (2.3) can be simplified into the following equation:
v =
d[P ]
dt
=
Vmax
KM
[S] = k[S], (2.4)
where k = Vmax
KM
. This equation is exactly the same as the law (2.1) and is called
a first-order kinetics [89]. For the current thesis, first-order kinetics is used, unless
otherwise is specified.
Reaction of inhibition and activation
Any biochemical reaction might be a subject for an external activation (amplifica-
tion) or inhibition (suppression) (Fig. 2.4).
Figure 2.4: A reaction might have a modifier. A modifier can either
activate ([M1]) or inhibit ([M2]) the reaction. In case of several modifiers
a reaction might be simultaneously activated and inhibited.
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When an activator [M1] modifies the rate of a reaction, the concentration of a
product [P ] is changed according to the following law:
d[P ]
dt
= k[S][M1], (2.5)
where [S] and [M1] are the concentrations of a substrate and a modifier correspond-
ingly, k is a rate constant of the reaction of activation.
When an inhibitor [M2] modifies the rate of a reaction, the concentration of a
product [P ] is changed as
d[P ]
dt
=
k[S]
K + [M2]
, (2.6)
where K is a parameter of dimension of concentration. Its presence does not allow
unlimited growing of a product [P ] in case of minor concentrations of a modifier [M2].
The inhibitors and activators are not consumed.
The Figure 2.4 uses some elements of Systems Biology Markup Language (SBML)
notation. It is an open standard for computer models of biological processes [90].
In the current thesis three SBML elements are used (Fig. 2.5).
Figure 2.5: Three SBML elements are used in the thesis. (a) M is an
activator of the reaction; (b) M is an inhibitor of the reaction; (c) M is
consumed in the reaction.
Reversible reactions
All the reactions discussed above are assumed to be irreversible. However, if the
product might have two states (for example, active and inactive) then reversible
reaction may be used (Fig. 2.6)
If a product is neither synthesized nor degraded then the total concentration
[P1] + [P2] remains constant and is just distributed between two states. More often
CHAPTER 2. KINETIC MODELING PRINCIPLES 20
Figure 2.6: A reaction might be reversible if a product has two states
(P1 and P2). Each direction of the reaction might have its own rate
constant as well as modifiers.
one or both components of a product have its own sources and sinks. For example,
if a product state P1 has a substrate [S1] and a sink [D1] and a product state P2
has only a sink [D2] then for the concentration changes d[P1]
dt
and d[P2]
dt
one can write
d[P1]
dt
= kS1[S1]− kD1[P1]− k12[P1] + k21[P2],
d[P2]
dt
= −kD2[P2] + k12[P1]− k21[P2],
(2.7)
where kS1 is a rate constant for a synthesis of P1, kD1 and kD2 are rate constants
for a degradation of P1 and P2 correspondingly, k12 and k21 are rate constants for
the transfer from a state P1 to a state P2 and back.
2.2.2 Rate constants
Most rate constants of a model of a bioregulatory network are related to synthesis
and degradation reactions. Since the parameters concern very different types of
reactants (mitochondria, proteins, ROS, mRNA) then the typical timescales for the
reactions also have to be different. When speaking about species that could be met
in the ROS management network then all corresponding reactions could be divided
into three groups: slow-rate, medium-rate and fast-rate reactions (Table 2.1).
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Reaction type Kinetic range, s−1 Description
Slow-rate 10−6 − 10−9 The reactions concerning mi-
tochondria dynamics: a syn-
thesis and a degradation. It
is known that in the normal
conditions (no disease, inflam-
mation, etc.) it is necessary
to spent about a 1 − 2 weeks
to change from 10% to 50%
of overall number of mitochon-
dria [91, 92].
Meduim-rate 10−4 − 10−6 Reactions of protein synthe-
sis and degradation. Indicated
time range is correct for sig-
nalling proteins [93] that are
assumed to take part in the
ROS regulation.
Fast-rate 10−1 − 10−4 Reactions of transferring be-
tween active and inactive forms
of certain proteins [94].
Table 2.1: Classification of rate constants according to the reaction type.
2.3 Steady state
2.3.1 Theory of stability
Systems theory defines a steady state as a state of a system that remains unchanging
in time. In terms of mathematical analysis it means that the derivative of any
variable of a system in time is equal to zero. In other words, if a system is described
by a set of ODE x˙(t) = f(x, t) then to find the steady state one should solve the
system of algebraic equations:
f(x, t) = 0. (2.8)
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The system (2.8) might have one or more solutions (fixed points). Stability prop-
erties of a fixed point are connected with the character of a system motion in its
vicinity.
If some disturbance is applied to a system being in a steady state then two
scenarios are possible. Either a system manages to go back to the steady state or, if
the disturbance is too large, a system leaves the steady state and starts the evolution
according to a new trajectory (for example, to another steady state or to infinity).
Any steady state has an important characteristic of stability that defines the
behavior of a system under the small perturbations of initial conditions. If after the
perturbation a system goes back to the initial state then the corresponding steady
state is called a stable one, otherwise, it is an unstable steady state.
If a system behavior is described by the ODE system
dx1
dt
= f1(x1(t), x2(t), ..., xn(t)),
dx2
dt
= f2(x1(t), x2(t), ..., xn(t)),
...............................................,
dxn
dt
= fn(x1(t), x2(t), ..., xn(t))
(2.9)
then to perform a stability analysis of the found steady state it is necessary to build
the Jacobi matrix according to the following rule:
J =

∂f1
∂x1
... ∂f1
∂xn
... ... ...
∂fn
∂x1
... ∂fn
∂xn
 (2.10)
The eigenvalues of the matrix (2.10) are used to estimate a steady state stability.
In general, the eigenvalues of the Jacobi matrix are complex numbers.
In an n-dimensional system the classification of the fixed point is rather difficult
since there is no appropriate graphical representation. To obtain an idea about the
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possible types of fixed points one could consider a 2-dimensional dynamic system,
that has fixed points with two eigenvalues that can be graphically represented. Since
the general solution for a motion of a dynamic system is proportional to
∑
i e
λit,
where λi are the calculated eigenvalues, then depending on the signs of real and
imaginary parts of the eigenvalues, several types of stability might be described.
 Both eigenvalues are imaginary. In this case a system demonstrates pen-
dulum behavior with a center (elliptic) fixed point (Fig. 2.7(a)). This type of
stability corresponds to a periodic motion, i.e. an oscillation in time between
two extreme points. Finally, a system flows around the fixed point, neither
attracting nor repelling.
 Both eigenvalues are real and have opposite signs. This is an unstable
fixed point of hyperbolic (saddle) type (Fig. 2.7(b)). The main feature of
this type of stability is an existence of one direction of the attraction (in n-
dimensional space the topology of the attraction might be more complicated).
 Both eigenvalues are real and have the same sign. Two options are
possible here. If both eigenvalues are negative, then the fixed point is a stable
node. If both eigenvalues are positive then it is an unstable node. In the
vicinity of a node all orbits are either attracted toward to it or repelled. On
the Figure 2.7(c) there is an example of a stable node. In case of unstable one
the direction of the trajectories should be reversed. In contrast to the previous
case an unstable node contains only the repelling trajectories. All trajectories
for both stable and unstable nodes have a limiting direction in the fixed point.
 Both eigenvalues are real and equal. Two options are also possible here
depending on the sign of the eigenvalues. In case of a negative value the fixed
point is a stable improper node (Fig. 2.7(d)). If the eigenvalues are positive
then the fixed point is unstable and has a type of star (Fig. 2.7(e)). Both
types have no limiting direction and every trajectory has its own slope of an
attraction or a repelling.
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Figure 2.7: Types of a fixed point: a circle (a), a saddle (b), a node
(c), an improper node (d), a star (e), a focus (f). For the simplicity it is
assumed that the fixed point has the coordinates (0, 0).
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 Both eigenvalues are complex. In this case the fixed point is a focus. If
both real parts of the eigenvalues are negative then a focus is stable. If one
of the steady states has a positive real part, then a focus is unstable. On the
Figure 2.7(f) there is an example of an unstable focus. In case of an unstable
focus the direction of the trajectory should be reversed.
 At least on eigenvalue is equal to zero. In this case it is impossible to
define a type of stability without additional investigations.
2.3.2 Examples of a system dynamics depending on steady
states configuration
A dynamic system might have one or several steady states. Their number and type
of stability might significantly change a system dynamics. It is possible to outline
some characteristic cases (see Fig. 2.8). For the simplicity one dimensional case is
considered.
 One stable state. It is the most clear case. If a system has only one stable
state then its state space could be described as a gap with infinitely high walls
(Fig. 2.8(a)). There would be no disturbance to make a system to leave its
steady state: it always comes back.
 One unstable state. The only way for a system to reach an equilibrium in
this case is to be placed exactly into the point of the steady state (Fig. 2.8(b)).
However, even after an infinitesimal disturbance a system has to leave this
steady state and it never reaches any other fixed point.
 One stable and one unstable steady states. When the second steady
state is added to a system’s state space then the dynamic of a system might
be more diverse (Fig. 2.8(c)). When the second steady state is an unstable one
(B), it means that there is a way for a system to leave the stable steady state
(A) if the disturbance is large enough. If a system is placed in the unstable
CHAPTER 2. KINETIC MODELING PRINCIPLES 26
state B then its further dynamics depends on disturbance direction. In some
cases a system finds a trajectory in the direction from A to B. If a disturbance
has another direction a system can choose an alternate trajectory that does
not lead to the steady state A.
 Two stable and one unstable steady states. This scenario provides a lot
of possible options for system dynamics (Fig. 2.8(d)). In addition to recently
discussed trajectories several new ones are added. Thus, if a system in the
unstable steady state B then after a disturbance a system might choose a
trajectory to either the point A or C. In case of more dimensions there is also
an option of a trajectory that leads to neither the state A nor the state C. Also,
there is a possibility to make a transfer between the stable states A and C.
It is also necessary to make an important note about the special case of an unsta-
ble steady state in multidimensional state spaces. When only one of the eigenvalues
of the Jacobi matrix has a positive real part then this fixed point is called “saddle”
(Fig. 2.9).
The point A is a fixed point of a system. If a system is under a disturbance
that shifts it strictly along the trajectory BAC then it relaxes again in the point
A. Thus, one can observe a “stable” behaviour for an unstable steady state. This
case represents a particular interest for a multidimensional spaces when the number
of eigenvalues of the Jacobi matrix with positive real part might be significantly
smaller then the number of eigenvalues with the negative real part. In this case a
system might be disturbed in a wide range but still demonstrate a “stable” behavior.
2.3.3 Basin of attraction
Any stable steady state is surrounded by a basin of attraction [95] that represents all
possible initial condition sets leading to the given steady state as time approaches
infinity. Normally, the basins might have different dimensions and even stretch to
infinity but take only a certain part of the phase space except the case when the
state space contains only one steady state (Fig. 2.8(a)). Initial conditions that lie
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Figure 2.8: Four basic cases of steady states. Stable steady state is
outlined by a green color, unstable steady state - by a red one. If a
system has two and more stable steady states it might be possible to
switch between them.
outside the current basin of attraction belong either for another fixed point basin
or a trajectory to infinity. The concept of a basin of attraction might be used to
compare different stable states or for seeking the ways of increase of stability of
steady state by increasing the size of the basin.
However, analytical calculation of a basin of attraction is only possible for low
dimensional problems (the number of dimensions is less or equal to 3). For a numer-
ical calculation the Monte Carlo method or the Lyapunov’s exponents [96] might be
used.
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Figure 2.9: Three dimensional figure of a “saddle” point (A). The special
feature of such type of an instability is that a certain type of a disturbance
might cause the stable behavior of a system.
The Monte Carlo method is good enough for low-dimensional problems when it is
possible to generate enough number of initial conditions and to check what fraction
of them is inside the basin of attraction [95]. For high-dimensional problems the
Lyapunov’s exponents might provide better results. However, the application of this
approach is restricted by a limited class of the problems [97].
2.3.4 Stability in biological systems
When speaking about biological systems one might be faced with several concepts
describing a system stability: homeostasis, steady state (dynamic equilibrium) and
chemical equilibrium. Despite the fact that all of these concepts are related to the
balance of a system, they represent very different things.
 Chemical equilibrium. A system in equilibrium requires no energy to main-
tain this state [98]. If some ink is injected in a water tank with a built-in
membrane in the middle, then after the diffusion the ink will have a uniform
distribution for the both sides of the membrane. Afterwards, this distribution
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is not changed anymore and a system is in equilibrium. No energy needs to
maintain this state. A good biological example of chemical equilibrium is the
value of pH. Without external impacts, pH of a biosystem remains stable as
it guarantees the lowest free energy under the current conditions [99].
 Steady state. As it has been discussed, the main feature of a steady state is
remaining constant over time. However, in contrast to a chemical equilibrium,
it requires the continuous work of all regulatory systems. That is why this
type of a system balance is also referred as a dynamic equilibrium. While the
concept of homeostasis is applied to the entire internal environment, a steady
state behavior might be restricted to specific mechanisms or subsystems. One
might say, for example, that a cell is in a homeostatic state because all vital
mechanisms are in steady states. The frequently used example of a steady
state is an internal environment of a cell that is maintained via a constant
movement of ions across the cell membrane.
 Homeostasis. This term is very often used specifically for animals. It is
defined as maintaining of nearly constant internal environment in an animal,
independently from the changes in the external environment. The key point
is the presence of all necessary mechanisms to maintain a constancy within
the system [100]. The good example of homeostasis is the maintaining a body
temperature for mammals.
In the current thesis the main analysis is focused on steady states. Some
explicit references to the homeostasis also exist.
Chapter 3
The model of the ROS
management network
3.1 The members of the ROS management net-
work
Antioxidants
The term “antioxidant”(AO) could be referred to any molecule that could delay or
even inhibit a cell damage caused by free radicals and an oxidative stress [101].
Humans have a complex antioxidant system that consists of two subsystems:
enzymatic and nonenzymatic. Normally, antioxidants for everyday use are generated
inside a cell (endogenous AO) but in case of necessity they could be delivered outside
with medicines or a diet (exogenous AO). In some cases medicines are not necessary
the AO themselves but may stimulate internal generation of the AO.
Endogenous AO play very important role since they provide necessary balance
of the ROS inside a cell allowing to avoid an oxidative stress. The most efficient
enzymatic AO are glutathione peroxidase, catalase and superoxide dismutase [102].
Nonenzymatic AO include the vitamins E and C, melatonin, natural flavonoids,
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etc. [103]. Sometimes AO of different types could interact with each other recovering
their original properties. This phenomena is known as “antioxidant network” [104].
Basically, to neutralize the ROS activity AO use two different mechanisms: a
donation of one electron to a free radical and a removal of initiators of the ROS
production [105]. These mechanisms provide different levels in the protection system
created by AO: stopping the formation of new free radicals by reducing (glutathione
peroxidase, phospholipid hydroperoxide glutathione peroxidase, etc.), scavenging
active radicals (the vitamins C and E), recognizing and removing oxidated proteins
(proteolytic enzymes, proteases, etc.).
Protein Parkin
Parkin is a protein that in humans is encoded by the PARK2 gene. The protein is
a component of the complex that performs targeting of proteins for a degradation.
It is also known that it takes part in mitophagy [106]. The mutation of the Parkin
protein may cause a form of autosomal recessive juvenile Parkinson’s disease [107].
Protein Sequestosome-1 (p62)
The protein p62 serves as a signaling hub for diverse cellular events such as amino
acid sensing and the oxidative stress response [108]. In addition, p62 works as a
selective autophagy receptor for a degradation of the ubiqutinated substrates. It
recognizes toxic cellular waste, which is then scavenged.
Protein Keap1
Keap1 plays very important role in maintaining of intracellular homeostasis. The
protein creates a complex with transcription factor Nrf2. This binding does not allow
a transfer of Nrf2 from the cytoplasm into the nucleus and leads to the degradation
of Nrf2 [109]. The lack of Keap1 is the reason of the creation of unbound Nrf2 that
translocates into the nucleus causing the activation of AO generation pathways.
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Protein Nrf2
The protein Nrf2 plays a vital role in maintaining cellular homeostasis, especially
when a cell is under an oxidative stress. It is known as a master regulator of
antioxidants and detoxifying genes via binding with their response elements (RE).
Under normal conditions the protein is localized in the cytoplasm creating a complex
with the protein Keap1 [110]. An oxidative stress might create a lack of Keap1
increasing the concentration of free Nrf2 that starts its transfer to the nucleus where
it binds to RE. This creates a complex playing a critical role in cellular defense
against oxidative stress [109, 111, 112].
Nrf2 activation increases the chances for a cell to survive under an oxidative
stress via multiple mechanisms:
 an activation of many antioxidants [113] (catalase, glutathione peroxidase,
superoxide dismutase, and thioredoxin) that directly or indirectly scavenge
free radicals;
 a regulation of a synthesis of glutathione as the most abundant scavenger of
the ROS and an important controller of redox status of proteins affecting a
cell survival and death [114];
 a repair or an elimination of damaged proteins, thus, protecting a cell from a
death [115];
 an activation of p62 transcription [116].
Protein Nf-κB
NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein
complex that controls transcription of DNA, cytokine production and a cell sur-
vival [117]. NF-κB is found in almost all animal cell types and is involved in the
cellular responses to stimuli such as stress, cytokines, free radicals, heavy metals,
ultraviolet irradiation. NF-κB plays a key role in regulating the immune response
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to an infection. The incorrect regulation of NF-κB has been linked to cancer, in-
flammatory and autoimmune diseases.
Protein Bcl-xL
The protein Bcl-xL (B-cell lymphoma-extra large) is a transmembrane molecule in
a mitochondrion. It acts as a pro-survival protein that prevents the release of the
mitochondrial contents. Bcl-2 family of proteins defines whether a cell death occurs:
if more Bcl-xL is present, then the cell pores become non-permeable to pro-apoptotic
molecules and a cell survives.
Protein IKK
The IκB kinase (IKK) is an enzyme complex that is involved in the propagation of
the cellular response to an inflammation. It is a part of the upstream NF-κB signal
transduction cascade [118].
Protein DJ-1
The protein deglycase DJ-1 is also known as Parkinson’s disease protein 7 (PARK7).
Under the conditions of an oxidative stress the protein DJ-1 inhibits the aggregation
of α-synuclein via its chaperone activity, thus, working as a redox-sensitive chaperone
and as a sensor for oxidative stress. Accordingly, DJ-1 apparently protects neurons
against oxidative stress and a cell death. The loss of DJ-1 results in an increased
stress-induced Parkin recruitment and increased mitophagy [119].
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3.2 Model I – ROS-induced mitochondrial aging
3.2.1 Model IA
Model structure
The simplest model of the ROS management network should include two compo-
nents: ROS and mitochondria. A cell contains a number of organelles that can be
damaged by the ROS. However, for certain reasons the mitochondrion has a special
status among other organelles. At first, a mitochondrion is responsible for ATP
generation. It means that a disruption in mitochondrion function could lead to the
lack of energy and, possibly, to a cell disfunction or death. The ROS do not destroy
the mitochondrion, instead a damage occurs and an impaired mitochondrion starts
producing more ROS. These facts justify the inclusion of a mitochondrion into the
model of the ROS management network. Since the mitochondrion can be in either
healthy or impaired (damaged) state, a very basic model should contain three com-
ponents: the ROS, healthy mitochondria and impaired mitochondria (see Fig. 3.1).
It is assumed that the healthy mitochondria concentration remains the same (no
consumption in the model) but the concentrations of impaired mitochondria and
the ROS could be changed in time. The model has a positive feedback loop and
should demonstrate the uncontrollable increase of the concentration of both diseased
mitochondria and the ROS.
Steady states and stability analysis
The seeking of the stable steady state for a model of a regulatory network is a very
important task. The steady state is a key process that takes part in maintaining
of homeostatic behavior of living organisms [120]. The latter property is vitally
important for an organism, the best examples of homeostasis are the regulation of
the body temperature, pH, glucose level, etc.
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Figure 3.1: The basic model should include at least three elements:
healthy mitochondria (HM), impaired mitochondria (IM) and the ROS.
As any other organelle a mitochondrion moves over all life stages: from
the birth to the death. The mitochondrion aging is a natural process and
it is included in the model as HM → IM reaction. Aging of mitochon-
drion could be considered as its dysfunction. From the other hand, the
mitochondrion dysfunctions can be a result of an oxidative stress against
a background of the excessive ROS exposure. It means that the ROS is an
activator of the reaction of mitochondrion damage. As it has been already
known, impaired mitochondrion promotes further synthesis of the ROS
and correspondingly could be considered as an activator of the reaction of
the ROS synthesis.
The dynamics of the model IA could be described by the ODE system consisting
of just two equations (only the concentrations of impaired mitochondria and the
ROS can change): 
dxim
dt
= ghmp11xros − p41xim,
dxros
dt
= Sp21xim − p31xros.
(3.1)
Where xim and xros correspond to the concentrations of impaired mitochondria and
the ROS, ghm corresponds to a fixed concentration of healthy mitochondria, p11 is
a rate constant for mitochondria aging reaction, p21 is a rate constant for the ROS
production reaction, the constants p31 and p41 describe the degradation of ROS and
impaired mitochondria correspondingly. The concentration S corresponding to the
source of ROS.
To find the model steady state one should solve the following system of algebraic
equations:  0 = ghmp11xros − p41xim,0 = p21Sxim − p31xros. (3.2)
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Evidently, the system (3.2) has only one possible trivial solution xim = 0 and xros = 0
for any set of rate constants. From biological point of view the result seems to be
non-realistic since it is hard to create a pure zero concentration of any network
component: any fluctuation could lead to creation of non-zero concentrations. To
obtain an additional proof of instability of the model IA one should perform a
stability analysis. Taking into account a very simple mathematical nature of the
model the analysis could be carried out analytically.
The model IA has the following Jacobi matrix.
JIA =
−p41 ghmp11
Sp21 −p31
 (3.3)
The matrix has two eigenvalues
λIA1 =
1
2
(
−p41 − p31 −
√
4Sghmp11p21 + (p41 − p31)2
)
,
λIA2 =
1
2
(
−p41 − p31 +
√
4Sghmp11p21 + (p41 − p31)2
)
.
(3.4)
Since all constant parameters and rate constants are positive then the eigenvalue
λIA1 is always negative and the stability of the steady state is defined by the sign of
the second eigenvalue λIA2 .
3.2.2 Model IB
Model structure
To introduce more realism and to make an attempt to obtain a stable steady state
from the model it is necessary to add some mechanisms to regulate the ROS and
the impaired mitochondria concentrations to avoid an uncontrolled increase of both
components.
At first, the model could be complemented by the reaction of the ROS degrada-
tion with the antioxidant as an activator (the more the concentration of antioxidants
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is the faster the ROS degrade). To suppress the increase of the impaired mitochon-
dria concentration there should be a reaction of mitophagy. It removes impaired
mitochondria consuming the proteins p62 and Parkin [121]. The concentrations of
antioxidants, p62 and Parkin remain the same during the whole cycle of the simu-
lation (see Fig. 3.2).
Steady states and stability analysis
Since only two species remain unfixed (newly added antioxidants, p62 and Parkin
have neither sources nor sinks) then the ODE system for the model IB contains two
equations: 
dxim
dt
= ghmp11xros − gpkgp62p41xim,
dxros
dt
= Sp21xim − gaop31xros.
(3.5)
Where xim and xros correspond to the concentrations of impaired mitochondria and
the ROS, ghm corresponds to a fixed concentration of healthy mitochondria, gpk,
gp62 and gao are the constant concentrations of Parkin, p62 and antioxidants.The
parameter p11 is a rate constant for the mitochondria aging reaction, p21 – for the
Figure 3.2: An improvement of the model IA by addition of mitophagy
and the ROS degradation reactions. The mitophagy reaction is carry-
ing out with a participation of the proteins p62 and Parkin. The pro-
teins are not modifiers and are consumed in the mitophagy reaction:
IM + p62 + Parkin→ degradation.
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ROS production reaction, p31 – for the ROS degradation reaction, p41 – for the
mitophagy reaction. S corresponds to the concentration of the source of ROS.
The steady state of the model IB is the solution of the following system of
algebraic equations:  0 = ghmp11xros − gpkgp62p41xim,0 = Sp21xim − gaop31xros, (3.6)
which has evidently only a trivial solution xim = 0 and xros = 0. Thus, despite
the fact of an addition of some regulatory mechanisms the model IB demonstrates
the same steady state solution as the model IA does. To verify if the stability type
remains the same one can build the Jacobi matrix and calculate the eigenvalues.
The Jacobi matrix for the model IB could be written as:
JIB =
−gpkgp62p41 ghmp11
Sp21 −gaop31
 . (3.7)
Two eigenvalues could be found:
λIB1 =
1
2
(
−gaop31 − gp62gpkp41 −
√
D
)
,
λIB2 =
1
2
(
−gaop31 − gp62gpkp41 +
√
D
)
,
(3.8)
where
D =
(
(gaop31 + gp62gpkp41)
2 − 4 (−ghmp11Sp21 + gaogp62gpkp31p41)
)
.
In general, the value of D could be either positive or negative and hence
√
D = a+ib.
Taking for the simplicity −gaop31 − gp62gpkp41 = −c, where c has a positive value,
one could rewrite the eigenvalues in the following form:
λIB1 = −c− a− ib,
λIB2 = −c+ a+ ib,
(3.9)
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a > 0,
|a| > |c|
a > 0,
|a| < |c|
a < 0,
|a| > |c|
a < 0,
|a| < |c|
a = 0
Re(λIB1 ) < 0 < 0 > 0 < 0 < 0
Re(λIB2 ) > 0 < 0 < 0 < 0 < 0
stability no yes no yes yes
Table 3.1: The solution of the steady state of the model IB can be either
stable or unstable depending on values of rate constants. However, even in
case of the stable steady state it could not be considered as a biologically
relevant state since zero concentration can correspond only to a death
state.
Then the positivity or negativity of the Re(λi) depends on the signs and the values
of the constants a and c. All possible combinations are provided in the Table 3.1.
Finally, the stability analysis of the model IB demonstrates the same results as
for the model IA. The values of the steady state are still trivial and do not depend
on model parameters.
3.2.3 Model IC
Model structure
Both previous models use the assumption of the constant concentration of healthy
mitochondria. It means that a cell is supposed to have an unlimited capability
to generate new mitochondria and, thus, to maintain its concentration at a fixed
level regardless of the concentrations for the ROS and impaired mitochondria. In
reality, a synthesizing capacity of a cell is limited. Also this assumption provides
potentially unlimited capacities for a synthesis of impaired mitochondria. In reality,
when the rate of mitophagy exceeds a certain level, the total mitochondrial con-
centration should decrease. As the result, the ROS concentration could also drop
because the number of healthy mitochondria decreases. So the idea of improvement
of the model IB is to add a reaction of mitochondrial synthesis (model IC). Together
with mithophagy it should limit the total pool of mitochondria and provide more
reasonable values for the steady state (see Fig. 3.3).
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Figure 3.3: The model IC allows limiting a total mitochondrial concen-
tration. It helps to avoid an explosive increase of the concentration of
impaired mitochondria and makes the concentration of healthy mitochon-
dria variable.
Steady states and stability analysis
Since the concentration of healthy mitochondria may change dynamically then the
ODE system for the model IC consists of three equation:

dxhm
dt
= Sp51 − p11xhmxros,
dxim
dt
= p11xhmxros − gpkgp62p41xim,
dxros
dt
= Sp21xim − gaop31xros.
(3.10)
Where xhm, xim and xros correspond to the concentrations of healthy, impaired
mitochondria and the ROS, gpk, gp62 and gao are constant sources of Parkin, p62
and antioxidants. The parameter p11 is a rate constant for mitochondria aging
reaction, p21 – for the ROS production reaction, p31 – for the ROS degradation
reaction, p41 – for the mitophagy reaction, p51 – for the mitochondria synthesis
reaction. S corresponds to the source concentration. The model V has two sources:
for healthy mitochondria and ROS. For the simplicity of analysis here and till the
end of the thesis it is possible to equate every S to 1. In this case the synthesis of
the corresponding product is defined exclusively by the constant rate.
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Finding the solution of the system of algebraic equations
0 = Sp51 − p11xhmxros,
0 = p11xhmxros − gpkgp62p41xim,
0 = Sp21xim − gaop31xros
(3.11)
provides one non-trivial solution:
xhm =
gaogp62gpkp31p41
p11Sp21
,
xim =
Sp51
gp62gpkp41
,
xros =
S2p21p51
gaogp62gpkp31p41
.
(3.12)
It is clear that for any set of positive rate constants there is always a positive and
real steady state.
The Jacobi matrix for the model IC is
JIC =

−p11xros 0 −p11xhm
p11xros −gpkgp62p41 p11xhm
0 Sp21 −gaop31
 . (3.13)
The eigenvalues λi of the Jacobi matrix (3.13) can be calculated after the solution
of the following cubic equation:
λ3 + λ2 (gaop31 + gp62gpkp41 + p11xros) +
+ λ [gaogp62gpkp31p41 − p11Sp21xhm + (gaop11p31 + gp62gpkp11p41)xros] +
+ gaogp62gpkp11p31p41xros = 0,
(3.14)
where the values of xhm and xros should be taken from the set (3.12). The type of
stability should be verified individually for every solution of (3.14). The analytical
solution of the qubic equation (3.14) can be obtained with Cardano’s formula [122].
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3.2.4 Model parametrization
To perform further analysis of the model it is necessary to carry out its parametriza-
tion. Unfortunately, it is hardly possible to find the exact values of rate constants.
However, at least, as a first approximation one can use the reactions classification
provided in the section 2.2.2 at the page 20. Since it is important for the model to
have a steady state then to define the values of the rate constants one should use the
system or algebraic equations (3.11). To do that the desirable steady state values
for the variables xhm, xim, xros have to be defined.
To calculate the normal concentration of mitochondria in a cell it is necessary to
know both the concentration of mitochondria and a typical cell volume. Normally,
the volume of a human cells varies from 30 µm3 to 4 × 106 µm3 [24]. However,
in order to eliminate extremely small (a sperm cell) and large (a fat cell) values,
one can say that a volume of a cell can be found in the range from 150 µm3 to
5000 µm3 that includes the volumes of the different cell types: beta cells (1000 µm3),
enterocytre (1400 µm3), fibroblast (2000 µm3), HeLa, cervix (3000 µm3).
In average, a mammalian cell contains about 103 mitochondria [24]. Then using
the value of Avogadro constant NA = 6.022×1023 it is possible to find out the range
for the concentration of mitochondria in a cell:
Cmit =
nmit
NAVcell
, (3.15)
where nmit is a number of mitochondria in a cell, Vcell is a volume of a cell. Taking
into account the typical values for nmit and Vcell discussed above, one can find that
the concentration of mitochondria in a cell can be in the range from 1 nmol/l to
110 nmol/l. For the model parametrization an average value of 55 nmol/l is taken.
Since the model of the ROS management network utilizes two forms of mitochondria:
healthy and impaired, then the calculated value of the total mitochondria concen-
tration should be splitted. The rate of the mitochondria replacing starts from 3–4%
per day [123]. Taking into account the fact that the number of impaired mitochon-
dria can differ from the number of replaced mitochondria, in the current model the
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Variables & Constants Value, nmol/l
healthy mitochondria, xhm 50
impaired mitochondria, xim 5
reactive oxygen species, xros 10
antioxidants, gao 500
protein Parkin, gpk 50
protein p62, gp62 50
Table 3.2: Assumed steady state values for three variables of the
model IC: healthy mitochondria, impaired mitochondria and the ROS and
three constant concentrations: antioxidants, proteins Parkin and p62. Im-
paired mitochondria take about 10% of the total pool of mitochondria.
This state should be considered as a healthy one since it has a normal
level of the ROS in the absence of an oxidative stress [124] and a ratio
of healthy and diseased mitochondria corresponds to a normal turnover
process.
mentioned replacing rate is doubled. Finally, it is assumed that the concentration
of impaired mitochondria is 10% of the total mitochondrial pool. The steady state
concentration for the ROS (10 nmol/l) is taken from [124] where it is measured for
HepG2 cells. Also the parametrization of the model IC requires the setting of the
constant concentration of the antioxidants and the proteins Parkin and p62. The
typical concentrations of different antioxidants are about hundreds of nM [125, 126].
Thus, as a first draft, the concentration of antioxydants is estimated as 500 nmol/l.
The intracellular concentration of signaling proteins in unknown but it varies from
Reaction Rate constant
Mitochondria aging, p11 2.5 ·10−6s−1
(
nmol
l
)−1
ROS synthesis, p21 4 · 10−5s−1
ROS degradation, p31 10
−7s−1
(
nmol
l
)−1
Mitophagy, p41 10
−7s−1
(
nmol
l
)−2
Mitochondria synthesis, p51 1.25 · 10−3s−1
Table 3.3: The values of the rate constants obtained after the solution
of the system (3.11) using the concentrations values from Table 3.2.
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10 nmol/l to 1000 nmol/l [127]. At this stage the concentration of every signaling
protein is accepted to be 50 nmol/l. This value is inside the indicated range, but at
the same time it does not differ too much from other concentration values. Finally,
all the values for the parametrization of the model IC are grouped in the Table 3.2.
Now the system (3.11) contains only five unknown values of the rate constants. Since
there are only three equations the system can be considered as an underdetermined
one [128]. In general, such a system has an unlimited number of solutions. The
simplest way to obtain a solution is to fix certain variables by assigning some val-
ues. In the current case it is necessary to fix two values and to find the remaining
ones by solving the system (3.10) of three equations with three unknowns. The
possible solution is provided in the Table 3.3. To finish the model parametrization
it is assumed that the concentration of source S is equal to 1 nmol/l.
One can notice that the value for the mitochondria synthesis p51 is outside the
range specified in the Table 2.1. It might mean, that the model is incomplete and
does not contain all necessary ROS regulation mechanisms. Indeed, in order to
maintain the proper healthy mitochondria concentration the model produces them
too fast. Hence, there might be an additional mechanism that provides more effective
ROS regulation and decreases the rate of the healthy mitochondria synthesis.
3.2.5 The model response to the step-wise increase of the
ROS synthesis
The ROS management network is the subject of constant challenges. Due to the
different external (environmental changes, smoking, UV-rays) or internal (inflam-
mations, various disorders) impacts the level of the ROS synthesis may be dra-
matically changed. One of the most important function of the ROS management
network is an ability to reduce possible damage to a cell. Therefore to apply the
additional verification for the model a step-wise increase of the ROS synthesis is
considered (see Fig. 3.4). Indeed, a sharp ROS increase can be observed in a inflam-
mation process [129], in a cancer therapy [130], during an insulin secretion [131].
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Figure 3.4: The step-wise change of the ROS synthesis (rate con-
stant p21) to check the ability of the model of the ROS management net-
work to manage with an oxidative stress. The ROS synthesis is doubled
every 106 seconds.
The simulation results are presented in Fig. 3.5 and have several features. At first,
the model IC hardly demonstrates a homeostatic behavior. In the model IC only
the healthy mitochondria concentration demonstrates the attempt of a homeostatic
behavior for a first jump of the ROS synthesis when the corresponding concentration
has a clear minimum and a recovery trend after that.
Another feature is the fact that the changing of the ROS concentration almost
precisely repeats the dynamics of the ROS synthesis. It means that this mana-
gement network has no capability to compensate the ROS synthesis jumps. A
corresponding drop of the concentration of healthy mitochondria to the zero value
almost guarantees the death of a cell because of lack of ATP.
3.2.6 Conclusion
A model describing a biological network should demonstrate the ability to reach the
steady state. Steady state could be assigned to healthy, diseased or any intermediate
state of a biological network. The evolution of a network may be represented as
a set of consequential switches between steady states. The investigation of the
models with the simplest structure shows that both the limited synthesis of healthy
mitochondria and the mitophagy are required to reach the steady state. Despite the
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Figure 3.5: When increasing the ROS exposure three model variables
have the greatest importance: healthy mitochondria (a), impaired mito-
chondria (b), the ROS (c) since they can be used for an estimation the
state of the system. Every 106 seconds the ROS synthesis increases twice.
Essential part of the simulation is the fact that after every jump the sys-
tem has enough time to relax to the new steady state. Thus, one can
avoid possible inaccuracies in post-jump dynamics because of the previous
step. The figure (d) contains the ratio of impaired mitochondria in a total
mitochondrial pool. The simulation is performed with MATLAB.
fact that the model IC demonstrates a steady state behavior it is not very useful
from a practical point of view since it hardly demonstrates a feature of homeostasis,
i.e., the regulatory function of the model does not work. However, the model IC
could be used as a key one for further incorporation of additional blocks to obtain
a more accurate version of the model of the ROS management network.
CHAPTER 3. THE MODEL OF THE ROS MANAGEMENT NETWORK 47
3.3 Model II – Keap1-Nrf2 complex
3.3.1 Model structure
In the model IC the concentrations of two species (p62 and Parkin) involved in
mitophagy as well as the concentration of antioxidants are fixed. For the second stage
of the model design this assumption is not a very realistic one since it guarantees
a fixed level of a cell protection regardless of the ROS and impaired mitochondria
concentration. Thus, the results generated by this model could not be reliable. A
real cell has a dynamic pool of antioxidants with the separate reactions of synthesis
and degradation. For the same reason it is necessary to make the concentrations of
proteins p62 and Parkin variable as well.
In reality, a cell has one more way to modulate the mitophagy and antioxidant
response. It can be done with a protein complex Keap1-Nrf2. The protein Keap1
works as ROS sensor that regulates Nrf2 degradation and its intracellular localiza-
tion. The protein has two forms: active and inactive. When active, Keap1 creates a
complex with Nrf2 to transfer it to the cytoplasm, and marks it for a degradation.
When the ROS oxidize cysteine residues in Keap1 molecule, Keap1 changes its
conformation and becomes inactive. The higher is the concentration of ROS, the
less active is Keap1 and, consequently, more Nrf2 stays in the nucleus. Higher
nuclear concentration of Nrf2 provides higher expression of p62 and correspondingly
increases the rate of mitophagy. The addition of Keap1-Nrf2 (see. Fig. 3.6) should
change the behavior of the system qualitatively. Now, upon the increase of the
ROS synthesis, one should expect a better homeostatic behavior due to the negative
feed-back loop that activates the antioxidant response and mitophagy.
An addition of Keap1-Nrf2 complex and unfixing the concentration of antioxi-
dants, p62 and Parkin immediately increase complexity of the model from mathe-
matical point of view. Now the model has 10 variables. The full system of ODE
that describes the model II could be found in the Appendix A.1.
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Figure 3.6: The model II with Keap1-Nrf2 complex that regulates mi-
tophagy process. The values of the model parameters can be found in the
Appendix A.1.
3.3.2 Model parametrization
The process of the model II parametrization is similar to the one for the model IC.
At first, it is necessary to choose the values of the steady state the same as the
model IC has. It simplifies the comparison of the models. Thus, in addition to three
steady state components of the model IC seven more values are added.
It is assumed that the proteins Keap1 and Nrf2 have neither a synthesis nor a
degradation. Active and inactive form of each protein create a pool and a total
concentration of both forms remains the same. All reactions occur inside the pool
and only between active and inactive forms.
The common parameters for the model IC and model II have the same values.
Reactions of Keap1 and Nrf2 inactivation are reversible and have two rate constants.
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It corresponds to a different speed of forward and backward reactions. The values
of all rate constants could be found in the Appendix A.1.
3.3.3 The model response to the step-wise increase of the
ROS synthesis
After an addition of a new regulatory complex and unfixing several variables one
can wait that the model has to demonstrate new features and to manage with an
oxidative stress better. The result of an application of the ROS jumps perturbation
to the model II is shown on Fig. 3.7. The first distinction from the model IC is a
better homeostatic behavior (Fig. 3.7(a)). The model II tries to recover the number
of healthy mitochondria more actively. Finally, after each ROS jump it manages
to reach 30 − 40% of the number of healthy mitochondria before the jump. Due
to this homeostatic behavior at the end of the simulation for the model II saves
more healthy mitochondria then model IC, however, their concentration is still very
low. Other important feature is the sharp decrease of the healthy mitochondria
concentration at the moment of the first jump. The effect is even stronger that
for the model IC and might be critical for ATP generation. At the same time the
model demonstrates slightly better results for the ROS concentration and the ratio
of impaired mitochondria.
3.3.4 Conclusion
The complex Keap1-Nrf2 provides a negative feedback loop to regulate the ROS
concentration. The change of the concentration of nuclear Nrf2 via activation or de-
activation of Keap1 helps to activate mitophagy and antioxidant response when the
ROS concentration is increased. The model II demonstrates slightly better results
concerning the temporal evolution of mitochondria and the ROS concentration than
the model IC. However, it is clear that an addition of Keap1-Nrf2 complex is not
enough to deal with an oxidative stress.
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Figure 3.7: Dynamics of three variables for the model II: healthy mi-
tochondria (a), impaired mitochondria (b), the ROS (c). since they can
be used for estimation the health of the system. Every 106 seconds ROS
synthesis increases twice. The figure (d) contains the ratio of impaired
mitochondria in a total mitochondrial pool. The simulation is performed
with MATLAB.
3.4 Model III – NF-κB activation
3.4.1 Model structure
The process of mitophagy decreases the concentration of impaired mitochondria and
correspondingly decreases the ROS synthesis rate, thus, preventing a cell from ROS-
induced damage. However, as a result, the total concentration of mitochondria can
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Figure 3.8: The feature of the model III is a mechanism of impaired
mitochondria recovery that helps to avoid negative scenario of a cell death.
The values of the model parameters can be found in the Appendix A.2.
reach a critical level when the overall energy generated by remaining mitochondria
is not enough to maintain a cell functioning. This process could be considered
as necrosis and result in a cell death. In the reality a cell has not only mitophagy
mechanism to neutralize impaired mitochondria. Instead of being degraded impaired
mitochondria might be recovered to healthy ones. To do that a cell uses a repair
mechanism that is driven by Nf-κB signalling (see Fig. 3.8).
3.4.2 Model parametrization and simulation results
The model III parametrization follows the common approach accepted for the pre-
vious models and uses the same steady state values. As a result there is only one
change in the values of rate constants: the rate of mitochondria aging. Full table
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Figure 3.9: Unexpected results of the model III simulation (solid line)
in comparison with the results of model II (dashed line). Dynamics of the
ROS concentration and impaired mitochondria concentration are similar
for the both model, however, the model III loses healthy mitochondria
faster than the model II. The simulation is performed with MATLAB.
with rate constants and steady state values can be found in the Appendix (Ta-
bles A.4 and A.5).
Under the standard test with the step-wise ROS synthesis the model III demon-
strates unexpected behavior: the results are worse than the model II provides. De-
spite of the addition of the impaired mitochondria recovery, the healthy mitochon-
dria concentration now decreases faster than in the model II. As a result, the ratio
of impaired mitochondria becomes bigger. So at the end of simulation the model III
is more “diseased” than the model II (see Fig. 3.9).
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One possible explanation is that a channel of impaired mitochondria recovery
induced by Nf-κB could hardly be described by a single reaction. In other words,
a recovery reaction in the model III is a kind of “averaged” reaction and its rate
constant is a subject to investigation.
Since with the given set of parameters the model III demonstrates steady state
behavior with only 9% of impaired mitochondria in the total mitochondrial pool
then the value of a rate constant of the recovery reaction is enough to maintain
an acceptable level of healthy mitochondria. A problem arises with the increase
of the ROS synthesis. Thus, to maintain a substantial concentration of healthy
mitochondria, it is necessary to increase the rate of the recovery reaction. One
might expect that the higher is the rate of mitochondrial recovery, the more healthy
mitochondria are.
If the mitochondrial recovery rate is doubled while the ROS synthesis is also
doubled (fig 3.10(a), zone 1), then an additional activation of the recovery reaction
almost allows maintaining initial steady state level for the model. After moving
into the zone 2 with a normal synthesis of the ROS, the concentration of healthy
mitochondria starts to increase reaching a new steady state level that exceeds the
initial steady state approximately in two times. Once the model relaxes, the ROS
synthesis again increases in two times (zone 3). At this step one can observe a sharp
ROS jump (Fig. 3.10(a)) that corresponds to the severe oxidative stress: during the
short time the concentration of ROS increases more than in 4 times.
This unexpected behavior has a rational explanation. Indeed, for the low rate
of ROS synthesis and high rate of mitochondrial recovery, a cell intensively accu-
mulates healthy mitochondria (fig 3.10(a), zone 2), but, when the ROS synthesis
jumps up, all these mitochondria can be damaged. Because of high concentration
of a substrate (healthy mitochondria), a quick rate of mitochondrial damage and
the positive feed-back loop (ROS damage mitochondria and impaired mitochondria
produce more ROS), the rate of accumulation of impaired mitochondria exceeds the
rate of mitophagy. As a result, the ROS concentration grows up to a high extent
and creates a strong oxidative stress.
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Figure 3.10: ROS synthesis (a) has three levels: 2-fold synthesis (zone 1),
normal (zone 2) and again 2-fold synthesis (zone 3). Despite of the same
synthesis of the ROS in zones 1 and 3 the model demonstrates different
dynamics. The red line shows the steady state level for all components
(observed before t = 0). The simulation is performed with MATLAB.
Thus, both normal and increased values of the rate constant of the recovery re-
action do not provide proper functioning of the ROS management network in case
of oxidative stress. The most evident solution is to let the recovery reaction be
adapted to the ROS concentration. In other words, the recovery reaction should
listen to the other part of the management network: there should be weak mito-
chondrial recovery for the low ROS level and more intensive recovery for higher ROS
concentration.
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3.4.3 Conclusion
The model III has a mechanism of the recovery of impaired mitochondria. This
allows avoiding the situation when mitophagy is intensive enough to critically de-
crease the total mitochondria concentration that may result in necrosis of a cell.
The recovery mechanism is driven by NFkB signalling. However, to provide an ef-
fective regulation of the recovery process a sensor of the ROS concentration should
be introduced.
3.5 Model IV – DJ-1 as the ROS sensor
3.5.1 Model structure
As it has been discussed in the previous section, the model III is equipped with an
important mechanism that allows recovering of impaired mitochondria instead of
degrading them. However, this mechanism does not work very well until it has no
connection with the ROS concentration. To introduce a pathway between ROS and
Nf-κB signalling it is possible to use the protein DJ-1 that is known as a sensor of
the ROS concentration [119]. Like the proteins Nrf2 and Keap1, DJ-1 can have two
formations: active and inactive. When oxidized by the ROS, DJ-1 changes its state
from inactive to active. Active DJ-1 modulates the activity of the various pathways
in the management network, including Nf-κB and Nrf2 (see Fig. 3.11). Thus, an
addition of the protein DJ-1 provides a feedback loop between the ROS and the
mitochondria recovery reaction. This should make the model IV more robust to the
increase of ROS synthesis.
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Figure 3.11: The model IV contains the protein DJ-1 that performs
a regulatory function for the impaired mitochondria recovery. The non-
kinetic parameters (p133) and (p151) allow to avoid an infinite inhibition
in the case of zero concentration of the protein DJ-1. The values of the
model parameters can be found in the Appendix A.3.
3.5.2 Model parametrization and simulation results for step-
wise increase of the ROS synthesis
The model IV parametrization is carried out according to the procedure applied
for the previous models. The full list of non-kinetic parameters and rate constants
could be found in the Appendix (Tables A.7 and A.9). The results of the simulation
under the step-wise ROS synthesis are shown in Fig. 3.12.
CHAPTER 3. THE MODEL OF THE ROS MANAGEMENT NETWORK 57
Figure 3.12: A usage of the protein DJ-1 as the ROS sensor for the reac-
tion of mitochondria recovery. The model IV shows excellent results both
for the ROS and impaired mitochondria dynamics. As well, it provides a
low ratio of impaired mitochondria during whole cycle of simulation. The
simulation is performed with MATLAB.
The model IV demonstrates better results than the model III. Indeed, a home-
ostatic behavior of the model is observed both for the ROS and healthy mitochon-
dria concentrations. Although, after the ROS synthesis jump, the concentration of
healthy mitochondria is again recovered only to 30− 40% of the before-jump level,
there is no a large gap of the concentration after the first jump as it is observed in
the model II.
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Figure 3.13: Comparison of the simulation results for the four mod-
els of the ROS management network. The model IV demonstrates the
best results in the management of the oxidative stress. The simulation is
performed with MATLAB.
A very good result is demonstrated for the ROS concentration. Its final value is
only 2.5 larger then an initial concentration. The models II and III shows a worse
result, giving about 8-fold increase of the final ROS concentration.
Normally, during all time of the simulation the ratio of impaired mitochondria
leaves the range 9− 11% only for a short time at the moments of the ROS synthesis
jumps. However, it never exceeds the value of 16%. Hence, the ratio of diseased
mitochondria remains almost the same as the non-stress value.
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3.5.3 Conclusion
An addition of the protein DJ-1 coordinates the mitochondrial recovery and the
ROS level and helps to reach a dynamic homeostasis. This ROS sensor evidently
balances the network decreasing the final ROS concentration and not increasing too
much the ratio of diseased mitochondria. The comparison of the results of all four
models can be found in Fig. 3.13. Evidently, the model IV that includes all three
regulatory pathways (complex Keap1-Nrf2, Nf-κB signalling and the protein DJ-1)
demonstrates the best results, providing the lowest level of the ROS concentration,
impaired mitochondria concentration and its ratio. Only the result for the healthy
mitochondria concentration demonstrates the comparable values for all three mod-
els. However, the model IV combines the good dynamics of healthy mitochondria
concentration of the model II as well as the absence of the sharp gap in the concen-
tration after the first ROS jump, provided by the model III.
3.6 Model parameters estimation
3.6.1 Parameters estimation procedure
Recently, the models of the ROS management network have been parametrized with
some justified values. However, a proper model validation practice requires a stricter
estimation that can be done with a usage of experimental data.
The general procedure of validation of biological models has some features that
make it quite nontrivial and time-consuming. The main difficulty is the fact that
even a simple model of a biological system can contain tens of parameters. Also a
network model contains a large amount of “averaged” reactions. For example, the
generation of any protein includes at least two phases: transcription and translation.
In a model, these two phases may be replaced by an abstract source that generates
a protein. An exact rate constant for this reaction can not be found.
Basically, there are several approaches for a model parameters estimation
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 Relevant literature analysis. If a rate constant in question belongs to well-
known reaction then it is possible to find some publications with numerical
data.
 Examination of specialized biomedical databases. A very full list of the
data bases can be found in the review [132]. The databases collect and sys-
tematize the data from various sources. However, if a particular rate constant
(or a corresponding reaction) has not been investigated recently it is hardly
possible to extract useful data from the databases.
 Using of numerical procedure of a model parameters estimation. It
can be carried out, if there is experimental data for a model output. Then,
using a tailored algorithm [133], the rate constants of a model are varying in
the predefined range. The main goal is to minimize the difference between
model output and an experimental data. One should remember that a found
solution might not be unique. In general, this method allows to estimate any
number of parameters. However, a computational complexity raises fast with
the increase of the number of unknown parameters.
Unfortunately, the exact values of the rate constants used in the model of the
ROS management network remains unknown. Databases and other sources might
provide some information concerning the concentration of signal proteins or average
values for the rates of transcription, translation and degradation [127]. The exact
values for a particular protein are hardly discoverable. Therefore, to validate the
model it is necessary to use the procedure of the model parameters estimation.
3.6.2 Experimental data
The data for the estimation of model’s parameters are taken from the experiment
of an oxidative stress application onto the human hepatoma cell line HepG2 [124].
The experiment was carried out by L. Deferme and colleagues from University of
Maastricht (Department of Toxicogenomics).
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In the experiment HepG2 cells were exposed to menadione, a chemical that is
known for its ability to activate ROS synthesis [134, 135]. At the presence of mena-
dione the generation of oxygen radicals is increased. One of the goals of the experi-
ment is to measure the ROS intracellular concentration. The experiment lasted 24
hours. For the measurement the following time points were chosen: 0.5, 1, 2, 4, 6, 8
and 24 hours. The experiment was repeated three times. As a result, three experi-
mental curves for the ROS intracellular concentration were obtained.
The base model IV can not be directly used for the parameters estimation pro-
cedure since there is no mechanism of injection of external ROS. To achieve this,
the model V should be developed. It has several changes in comparison to the
model IV: new mechanism of mitochondria synthesis, the subsystem of menadion
injection, sources and sinks for the proteins Keap1, Nrf2 and DJ-1 to provide more
flexibility for comparison with experimental data and to equip the model with ad-
ditional inputs that could be used for control purposes. The detailed description of
the model V is provided in the Appendix B.1.
3.6.3 Parameters estimation results
The procedure of parameters estimation was carried out with COPASI environment.
It is a specialized software that supports models developed using the SBML standard
and can simulate their temporal behavior using ODE-representation [136]. The
software allows to define the margins for the parameters as well as to choose the
method of parameters estimation. Since the exact value for the most of the model
parameters are unknown then it is better to use any type of genetic algorithm [137].
The genetic algorithm is a good option if an optimization problem includes high
number of variables (the model V of the ROS management network includes more
that 30 rate constants). The result is shown in Fig. 3.14
The model output for the ROS dynamics is in a good agreement with experimen-
tal data. However, it is necessary to emphasize that the number of experimental
points is less than the number of parameters of the model. In theory, this sit-
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Figure 3.14: The results of the model parameters estimation. Three
dotted lines correspond to the temporal ROS dynamics obtained in three
experiments with human HepG2 cells. The solid line corresponds to the
model prediction initialized with the estimated parameters. The estima-
tion procedure is carried out taking into account the constraints for the
rate constants from the Table 2.1 and constrains for the steady state after
menadione exposure from the Appendix (Table B.1). One-time concen-
tration of menadion is 100 µmol/l that corresponds to the experiment
conditions [124]. The simulation is performed with MATLAB and Copasi.
uation might cause the problem of overfitting [138] and a bad prediction ability
of the model. However, the experimental curve is smooth enough with only one
clear maximum. The additional experimental points can increase the accuracy of
model’s parameters but hardly add new features to the experimental curve (noise,
new turning points). The choice of an estimation procedure (genetic algorithm) is
also defined by a low number of experimental points. The standard algorithms, for
example, least squares estimation, work good only if the number of experimental
point exceeds the number of model’s parameters. It is also possible to make an
additional check of the model’s parameters estimation since the experimental group
from University of Maastricht provided some additional experimental data for other
elements of the ROS management network. The model predictions for these species
are shown in Fig. 3.15.
It is obvious that the model demonstrates good predictions for the dynamics of
antioxidants and the protein p62. Another two predictions show larger deviations.
However, the experimental data have a large error that is enough to introduce an
uncertainty in the results. Taking into account the standard error values one might
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Figure 3.15: The model predictions for the dynamics of antioxidants(a)
and the proteins p62(b), Bcl-xl(c), Nf-κB(d). Dashed line corresponds to
the experimental data (standard error is indicated). Solid line corresponds
to the model prediction initialized with the estimated parameters. The
simulation is performed with MATLAB and Copasi.
conclude that the model prediction is close to the average experimental values for
the the proteins Bcl-xl and Nf-κB (Fig. 3.15(c) and (d)). It is necessary to emphasize
one more time that the experimental data regarding the species shown in Fig. 3.15
are not used for parameter estimation procedure.
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3.7 The analysis of the parametrized model
3.7.1 Steady states
After the model has been parametrized one could calculate the steady states. Taking
into account the dimension of the model state space it is hardly possible to get an
analytical solution. However, the structure of ODE for the model allows a semi-
analytical solution of the steady state problem. Indeed, the ODE system has several
important features. At first, it is sparse. It means that every differential equation
contains only a few variables rather than all variables of the system. At second, it is
an autonomous system (i.e., does not explicitly contain the time). And finally, due
to the polynomial nature of kinetic laws the ODE system also contains polynomial
equations that simplify the analysis.
From a mathematical point of view the dimension of the ODE system allows
to have a bigger number of steady states, which can be calculated numerically.
However, only two steady states (presented in the Table 3.4) have real and positive
values. Other steady states contain either negative or even complex values that make
no sense from the biological point view since the variables of the system correspond
to concentrations.
Taking into account the values for the steady states one might consider the steady
state I as a healthy state of the system, corresponding to normal functioning of the
ROS management network. Indeed, the concentrations of healthy and diseased mi-
tochondria as well as the ROS and the proteins are within the normal range for a
cell. On the contrary, the steady state II contains zero concentration for mitochon-
dria and the ROS as well as abnormal values for some the proteins concentration.
As a result this state might correspond to a very “diseased” state of the network.
Indeed, zero concentration of mitochondria means no energy generation for a cell
and its possible death.
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Model variable Steady
state I,
nmol/l
Steady
state II,
nmol/l
Allowable
range,
nmol/l
Healthy mitochondria 50 0
1–120
Impaired mitochondria 5 0
Reactive oxygen species 10 0 20–100
Antioxidants 200 8.61 200–500
Parkin 50 50.5
10–1000
p62 50 0.1
Keap1, active form 200 220
Keap1, inactive form 20 0
Nrf2, active form 20 0.9
Nrf2, inactive from 200 200
Nf-κB 100 4.8
Bcl-xL 100 4.8
DJ-1, active form 20 0
DJ-1, inactive form 200 220
Table 3.4: Calculated steady state values for the validated model V.
The detailed solution for the steady states might be found in the Ap-
pendix B.3. The allowable ranges are taken from the section 3.2.4
3.7.2 Stability analysis
Unstable steady state
Stability analysis performed with the calculation of the eigenvalues of the Jacobi
matrix for the two found steady states shows that the steady state I is a stable
one and the steady state II is an unstable one. The instability of the steady state
II might seem unusual, however, the analysis of instability shows that only one
eigenvalue of the Jacobi matrix has a positive real part. It means that the steady
state II has a type of “saddle” and it might leave this steady state only in case
of disturbance along one dimension (Fig. 3.16). Indeed, the disturbance of the
either the ROS or simultaneously the ROS and diseased mitochondria does not
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Figure 3.16: The network is disturbed when being in the unstable steady
state II. (a) Only the ROS concentration is disturbed (from 0 to 10 nmol/l);
(b) both the ROS and diseased mitochondria concentrations are disturbed
(from 0 to 10 nmol/l); (c) both healthy and diseased mitochondria concen-
trations are disturbed (from 0 to 10 nmol/l); (d) both healthy mitochon-
dria and the ROS concentrations are disturbed (from 0 to 10 nmol/l).
The figures (c) and (d) shows the network dynamics on its way to the
steady state I which is completed in more than 1000 days of the model
timescale (not shown). The simulation is performed with MATLAB.
put the network onto the trajectory leading to the steady state I (Fig. 3.16(a)
and (b)). Moreover, the concentration of healthy mitochondria stays zero. An
essential requirement for escaping from this steady state is a disturbance of the
healthy mitochondria concentration (Fig. 3.16(c) and (d)). However, a disturbance
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of only the concentration of healthy mitochondria does not allow the network to go
to the steady state I. Instead the network starts evolution to the infinity value of
healthy mitochondria (Fig. 3.17).
Stable steady state
The stable steady state demonstrates a very good region of stability. The dis-
turbed system goes back to the initial state even from a very unfavorable initial
state (Fig. 3.18(a)) that may correspond to a very diseased state that also experi-
ences an oxidative stress.
However, if the initial concentration of healthy mitochondria is equal to zero,
then the transfer to the steady state II (diseased state) occurs, even if the values of
all other parameters remain corresponding to the ones of the stable steady state I.
In practice, a zero number of healthy mitochondria means a very low level of ATP
generation and might be a reason of bad functioning of a cell.
Figure 3.17: Only the concentration of healthy mitochondria (HM) is
disturbed (from 0 to 10 nmol/l). This disturbance is not enough to put
the network onto the trajectory to the steady state I. The simulation is
performed with MATLAB.
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Figure 3.18: (a) The network goes back to the steady state I after the
large perturbation that places the network in a bad environment of ox-
idative stress (the concentration of the ROS is 10 times higher than the
steady state value) and with large number of diseased mitochondria (50
nmol/l). The concentration of healthy mitochondria is reduced and equal
5 nmol/l. (b) If the initial concentration of healthy mitochondria is equal
to zero then the network chooses a trajectory to the steady state II. The
simulation is performed with MATLAB.
3.8 Model design summary
The model of the ROS management network includes several subsystems that in-
troduce the special features. In the basis of the model there is a principle of the
ROS-induced mitochondrial aging that includes two forms of mitochondria (healthy
and diseased). The damage of a mitochondrion is activated by the ROS. Diseased
mitochondria activate the generation of additional ROS. To provide an adequate
antioxidant response the model uses Keap1-Nrf2 complex to control the antioxidant
concentration.
Diseased mitochondria jeopardize a cell and become a reason of an oxidative
stress and lack of ATP. A cell has two mechanisms to regulate the concentration
of healthy mitochondria: mitophagy and mitochondria recovery. The first process
takes place with a consumption of the protein p62. The second one is activated
using the protein Nf-κB.
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It has been shown that the rate of a mitochondrial recovery should not be fixed
but sensitive to the ROS concentration. If the mitochondria recovery is too intensive
then the large pool of healthy mitochondria might be accumulated. A sudden and
intensive oxidative stress may initiate the damage of this pool producing the high
concentration of impaired mitochondria that amplifies an existing oxidative stress.
Thus, to regulate the recovery process the protein DJ-1 is used as the ROS sensor.
The model IV might be considered as a base one that implements main features
of the ROS management, describing both ROS effects and a cell reaction to the
oxidative stress. Moreover, the inclusion of the protein DJ-1 allows to use this
model for investigation both in neurodegenerative diseases and cancer research.
Summarizing the previous conclusion, several design principles might be identi-
fied.
1. The ROS and mitochondria are mutually affected by each other.
2. Mitophagy and antioxidant response are dynamically changing with using a
protein complex Keap1-Nrf2.
3. The process of mitochondria recovery needs a regulation mechanism.
4. The protein DJ-1 is a ROS sensor for mitochondrial recovery.
Chapter 4
Model dynamics and
predictive control
4.1 Control of biological networks
First attempts to bind a control theory and a biological system were done many
decades ago starting with the works of french physiologist Claude Bernard [139]
and his idea of “milieu inte´rieur” (inner environment). Bernard proposed the idea
that any vital organism should have capabilities to protect an internal equilibrium
independently of the changes in an external environment. The idea is very closed to
the definition of homeostasis that is described as a property of a system to perform
an active regulation of a certain variable to keep its value nearly constant. The
next significant step was done by american physiologist Walter Cannon [100] who
expanded Bernard’s concept of homeostasis using the practical examples of steady
states for glucose concentration and a body temperature. In 1948 Norbert Wiener
published his famous book “Cybernetics: Or Control and Communication in the
Animal and the Machine” [140] where he discussed different aspects of self-regulating
mechanisms, neuroscience and artificial intelligence as well as introduced the term
“cybernetics”.
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Nonetheless, the problem of application of a control theory onto biological sys-
tems and networks has emerged only in the recent years [74, 75, 141] and achieved
some significant results in the field of a biomedical control.
One of the good examples is the application of control theory to improve cardiac
assist devices (CAD). CAD are electromechanical devices ensuring a proper blood
circulation in a patient body in case of a partial of a full heart dysfunction. The con-
trol theory might be applied to define the operation mode of the CAD as a function
of a patient state (physical activity, positive or negative stress, etc.). First CAD
with the output control were developed and approved in 1998 [142]. However, to set
the desired output the device required a manual regulation performed by a patient.
The recently developed CAD include a real-time monitoring of a physical and an
emotional strain as well as an realization of the predictive control principle [143,
144].
Another important application of the control theory is a development of the
device to control glucose level for patients with the diabetes of type 1. Such a device
includes a glucose sensor, which monitors the current glucose level. An integrated
pump performs an automatic injection of insulin using the data provided by the
glucose sensor. To make a decision about a dosage of insulin the sensor uses an
algorithm of nonlinear control [145].
At the same time it is still rather difficult to create a control device, which might
be physically incorporated into a biological network. There are number of problems:
micro and nano dimensions of the components of biological networks, the necessity
to eliminate the rejection of an alien substance for a body, an incorporation of the
power supply to feed a controller. Nevertheless, there were some attempts to create
control devices to drive biological systems from inside [146]. One possible way is
the usage of magnetic nanoparticles [147] as the objects that are capable to change
internal state of a biological object or a network.
Biological systems and networks often perform a specific function that could be
bound to a particular organism state. For example, the immune system is being
active when alien substances or organisms are introduced into a human body. In
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theory, the immune system should manage with any disease by itself. However, in
practice, for many diseases medicines are needed to provide an additional support
for the immune system to control a disease development.
Thus, the problem of control of biological systems or networks is of high impor-
tance. Moreover, the control theory is not necessary used to develop a strategy of
positive system dynamics. In some cases, it can be useful to make a system dead.
The most typical example is a cancer cell when it is desirable rather to kill a cell
then to save it.
Finally, when speaking about the system control two classes of problems are
raised: how to control a system to maintain a homeostatic behavior and how to
control a system to switch it from one state to another (for example, from a diseased
state to a healthy one).
4.2 Principles of model control
Independently of the area from where a model comes (chemistry, biology, physics)
it is always possible to apply a generalized approach to the problem of the model
control. First of all it is necessary to define model outputs, i.e., the variables of
a model that have to follow some reference signal (constant or variable). For the
second step one needs to define the control variables that are used to provide the
desired model output dynamics. For instance, the temperature of a reactor might
be controlled to maintain a reactor output inside a given range.
A control procedure might be carried out in a continuous or a discrete manner.
An example of a discrete control is a thermostat that is activated only if an envi-
ronmental temperature exceeds a certain temperature limit. There is no feedback
loop and error measurement. Once the temperature goes back to the limit value, a
thermostat is switched off.
Another example is a climate control unit that uses the continuous control prin-
ciple to change dynamically an air flow intensity and a temperature. A user sets
certain temperature value as a set point. A built-in sensor reads the environmental
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Figure 4.1: Both a system output signal x(t) and a reference signal rx(t)
are delivered to a controller input. A controller performs the signals com-
parison and provides a driving signal u(t) to a system input. Optionally,
a controller can put restrictions to the driving signal u(t) using a separate
reference signal ru(t).
temperature and compares it with a set point. In case of any deviations a sensor
provides a differential signal to change a temperature and an air flow intensity to
minimize the difference between actual and set points. As a rule, all control signals
are generated by a special device (controller). For computer models it is possible to
create a virtual controller that performs the same functions as its physical analog.
A schematic representation of the control process is shown in Fig. 4.1.
As a rule, most devices, machines, and industries use the programmable logic
controller (PLC) as a controlling unit [148]. PLC could be programmed to perform
specific actions as a reaction to environmental changes.
The process control approach is used for three types of processes: discrete, con-
tinuous and batch. In biology both discrete (a cell division) and continuous (dynamic
concentration changing) processes could be met.
4.3 Optimal control theory
When a system output is a simple (e.g., linear) function of a control variable, then,
as a rule, there is a unique value for a control variable to maintain the target value of
a system output. However, in practice, in complex systems such dependence might
be a function of several variables, be nonlinear or unknown. In this case, there
might be several solutions that provide the desired value for a system output. If a
user states auxiliary restrictions for the values of controlled variables the problem
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of seeking control solution turns into the optimal control problem. Thus, besides
a system output, a reference signal and a controller output there is an additional
restriction that is usually presented in the form of a cost function. During the seeking
of a solution of the optimal control problem a cost function should be minimized
or maximized. The control variables values that better optimizes a cost function
is assumed to be an optimal solution. As a rule, optimal control problems have
nonlinear nature and do not have an analytical solution.
One can consider a dynamic system, which is described by a set of ODE
x˙(t) = f (t, x(t), u(t)) (4.1)
with an initial condition x(0) = x0, where x(t) is a vector of system’s variables, u(t)
is a vector of control variables and t ∈ [0,∞)
To carry out a successful control of the object (4.1) it is necessary to fulfill two
conditions:
lim
t→∞
‖x(t)− rx(t)‖ = 0,
lim
t→∞
‖u(t)− ru(t)‖ = 0,
(4.2)
where rx(t) is a vector of the reference signals for a model output and ru(t) is an
optional vector of the reference signals for the control variables. In practice, the
vector ru(t) is set only in the case when there is an requirement for the temporal
dynamic of the control variables. More often, there are some boundary conditions
for the value of u(t) according to the nature of control variables. For example, if a
control variable corresponds to a concentration then ru(t) should be non-negative.
To make an estimation of the control efficiency a cost function is set:
F0 = F0 (x(t), u(t)) . (4.3)
For example, if there is a task to find an optimal way for a car driving, then a cost
function might represent the total fuel consumption or time that is needed to cover
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some predefined distance or be a combination of several targets. A cost function
might include both discreet and continuous parts.
Any problem of optimal control requires a seeking of such a vector of functions
u(t) that provides the satisfaction of the conditions (4.2), meets its own boundary
conditions and minimizes (or maximizes) the cost function (4.3)
Unfortunately ODE-model (4.1) could not be a good candidate for seeking the
optimal control solution. The main reason is the fact that this model is always an
approximation and could not take into account all possible features of a described
system. Moreover, there might be unpredictable changes in the state of an orig-
inal system. Finally, it leads to a disagreement between the real and predicted
trajectories. To improve the situation one could consider predictive model instead:
˙¯x(τ) = f¯ (τ, x¯(τ), u¯(τ)) (4.4)
with an initial condition x¯(τ = t) = x(t).
The predictive model (4.4) in every moment of time τ = t is initialized by a real
system state. It means that independently of any external variation and changing of
original system, the model (4.4) provides better results then the model (4.1), which
is initialized by the system state only at the moment of time t = 0.
Using the predictive model (4.4) it is possible to build the prediction of the
system trajectory for time range τ ∈ [t, t+ Tp] where Tp > 0. It is obvious that the
smaller value of Tp the more precise estimation is. The variable Tp is known as a
prediction horizon.
The fact that the initialization of the predictive model is done at every simulation
time step simplifies this model as it has to predict a system trajectory for a very small
time range. Sometimes it is even possible to use a linearization of the model (4.1)
as a predictive model.
Several possibilities for prediction strategies might be considered.
 One-time prediction. Let the predictive model has the prediction horizon
Tp = ∞. It is evidently that there is some solution u¯(t), which could be
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transformed into the solution u(t) for the model (4.1). However, for a large
time scale the difference in the models (4.1) and (4.4) provides a considerable
error between an estimated and a real trajectory.
 Mutli-time prediction. The described situation might be improved if one
could implement a prediction procedure for a fixed and finite prediction horizon
Tp, i.e. within the time range [t, t+ Tp]. Found control solutions u(t) are
applied for a system and prediction procedure is repeated for the time range
[t+ Tp, t+ 2Tp], then for the range [t+ 2Tp, t+ 3Tp] and so on. However,
this approach has two disadvantages. At first, the control functions u(t) are
applied independently for its own time range. Thus, the systems dynamics
is considered as a set of independent events that might be wrong for certain
systems. At second, the value of Tp might be too large that guarantees the
difference between estimated and real behavior of the system.
 Mutli-time prediction with sample time. Second disadvantage of the
previous strategy defines another strategy for seeking an optima control func-
tion u(t). The control function u(t) obtained for the prediction horizon Tp
might be applied only for a time range [t, t+ Ts] where Ts  Tp. After a
completion of the control step the procedure is repeated with the same value
of prediction horizon but initializing the predictive model with a real system
state x(t + Ts). This approach should provide better results for a calculation
of a control function and is schematically presented in Fig. 4.2.
The procedure of a seeking of the optimal control solution with two time param-
eters Ts and Tp is used in the method of the model predictive control.
4.4 Model predictive control
In the processing industry one of the most developed and well-known method of
model control is the model predictive control (MPC). It has been widely used in
chemical and refining industries starting from 1960s. During recent decades this
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Figure 4.2: A model trajectory (red line) is estimated for prediction
horizon time Tp using the current system state as an initial condition.
A corresponding driving signal is generated to minimize the difference
between a model output and a reference signal (green line). A driving
signal (violet line) is applied for the sample time Ts that should be smaller
than a prediction horizon. Then the algorithm is repeated starting from
the time point t+ Ts.
method has begun its expansion in other industries. Usually, it is applied to the
systems that are describing by models of high level of complexity when other ap-
proaches might fail.
Initially, the MPC methods has been introduced using two independent but
very similar methods: Dynamics Matrix Control (DMC) developed by specialists of
American company Shell Oil [149] and Model Algorithmic Control (MAC) developed
in France by specialists of the chemical industry [150].
The main advantages of the MPC method are a relative simplicity of a feed-
back loop creation as well as the excellent adaptive properties. Last feature allows
using the MPC approach together with multidimensional and multicomponent mod-
els to provide a real-time optimization taking into account model restrictions and
uncertainties in a model definition. Beside, it is possible to consider the change
of restrictions during a simulation as well as the change of the state of a system
(i.e. a breakdown).
The MPC method includes four main stages:
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1. A simple mathematical model of a system is considered. It might be a lin-
earized model in respect to a certain working point. The current state of a
system is considered as an initial state. Using these assumptions one could
integrate the equations of a simplified model and estimate a trajectory for a
model dynamics for some limited time frame (a prediction horizon).
2. To minimize the difference between the reference signal and the estimated
value of a model output obtained at the previous stage a certain optimization
is carrying out. It takes into account all restrictions for both output values
and control variables.
3. An optimal control strategy found at the stage 2 is applied for a time step
that should be much smaller than a prediction horizon (a sample time). Model
outputs are measured.
4. A prediction horizon is shifted for a time step used during the stage 3 and
stages 1 – 3 are repeated.
As a rule, the MPC controller uses a linearized predictive model, however, there
is the MPC method, which allows using a nonlinear model – Nonlinear Model Predic-
tive Control (NMPC) [151]. The application of this method is a quite specific since
the computational complexity is higher than in the case of ordinary MPC. NMPC is
used to be applied to systems with high sampling rates or when a real-time operation
is crucial, for example, in automotive industry, aerospace [152].
There is another class of MPC – robust MPC [153, 154] that is used to deal
with the systems demonstrating unexpected disturbances or uncertainties. This
class of problems could not be solved by the ordinary MPC approach since under a
considerable disturbance a system state could be outside the boundary conditions
stated for a controller, thus, failing the optimal control algorithm.
However, despite the fact that in most cases a controller could not be sufficiently
incorporated inside a biological network, the concept of a model predictive controller
can provide the ideas of how to control a particular biological system using an
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external impact. It could be an injection of the medicines to change a translation
or a degradation rate of particular proteins or a direct injection of antioxidants or
the ROS.
Straightforward software realization of the MPC approach might be challenging.
However, there are number of commercial software available for building and setting
the MPC controller [155]. One possible solution is Simulink environment [156].
The example of the creation of the MPC controller in Simulink is provided in the
Appendix C.
4.5 Implementation of model predictive control
for the ROS management network
4.5.1 Preliminary notes
The usage of Simulink controller assumes choosing some inputs and outputs for a
model. An output signal of a model is compared with a reference signal and a
driving signal for model inputs is generated. A model might have one or several
inputs and outputs.
For the output of the ROS management network three concentrations might be
chosen: the ROS, healthy or diseased mitochondria. Since the concentration of
healthy mitochondria reflects the ability of a cell to produce ATP, then it might be
a preferable choice for the model output. Indeed, zero concentration of the healthy
mitochondria corresponds to the very diseased state of a cell or even death. The
reference value of 50 nmol/l taken from the Table (3.4) corresponds to the healthy
state.
The model input might be presented by the generation rates of certain proteins.
The Simulink controller allows to include any number of inputs to control. However,
in practice, the simultaneous change of several inputs might be difficult.
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4.5.2 Network relaxation
If a dynamic system is in its stable fixed point and there is no control activated,
then any perturbation can put a system onto some trajectory that may lead back
to a stable state. In some cases, when the perturbation is too large a system might
choose another trajectory. The final point depends on the configuration of the state
space (a number of steady states, a topology of the basin of attraction). Normally, a
relaxation process takes some time and depends on the trajectory and the distance
between the initial point and the final steady state.
In biological networks the relaxation process might mean a recover from dis-
turbed (diseased) state to healthy one. The time factor might be a very important
since the uncontrolled relaxation may take a definite time that the system may not
have.
As it has been already shown in Fig. 3.16 (page 66) the total time needed for a
network recovery might be measured by tens and even hundreds of days.
If this time is too large it may negatively affect on other subsystems and make
a harm to a whole organism. To investigate the possible ways of a network recov-
ery acceleration it is possible to introduce a controller into a network and analyze
possible solutions (see Fig. 4.3). Three possible strategies might be considered.
Strategy A
The controller utilizes 6 inputs – generation rates of the ROS, AO and the proteins
Bcl-xL, Parkin, p62, DJ-1 that are main players in the ROS regulation process. As
well, the controller reads one model output (the concentration of healthy mitochon-
dria) and have the reference signal corresponding to the concentration of healthy
mitochondria in the healthy state (50 nmol/l). The simulation starts from the dis-
eased steady state II (see Table 3.4) and the controller tries to move the system into
the healthy state.
As a result, the controller uses only two inputs: ROS and Bcl-xL (Fig. 4.3 (a1))
to drive the network. The result is not very good. The concentration of healthy
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Figure 4.3: A simulation of the network recovery after a strong distur-
bance to the state that is close to the diseased state of the ROS manage-
ment network. In (a)-series the model has six controlled inputs for the
generation rates: ROS, Bcl-xL, AO, p62, DJ-1, Parkin and one output
signal. In (b)-series one model output is added (impaired mitochondria).
In (c)-series the third model output is added (the ROS). The first strat-
egy (a) is not effective since the controller manages to change only the
concentration of healthy mitochondria. The second strategy (b) demon-
strates an unexpected collapse of the network against a background of a
strong oxidative stress. The third strategy (c) demonstrates the best result
allowing to effectively control three model outputs. The dynamics of the
controlled network relaxation is better than the one of the uncontrolled
relaxation (Fig. 3.16). The simulation is performed with Simulink.
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mitochondria increases (Fig. 4.3 (a2)), however, the concentration of both impaired
mitochondria and the ROS stays near zero value (Fig. 4.3 (a3)). It means that
the regulatory network does not work properly: there should be a certain balance
between non-zero concentrations of the healthy and impaired mitochondria as well
as the ROS. On the other hand, as it has been discussed in previous chapters, a
cell needs non-zero concentration of ROS to perform certain specific functions. The
current simulation results can be explained after the analysis of the strategy pro-
posed by the controller. Indeed, it includes maximum allowed increase of Bcl-xL
generation, that maximizes the recovery process, and almost complete suppression
of the ROS synthesis. These two actions definitely helps to increase the concentra-
tion of healthy mitochondria. However, all other important components have near
zero concentrations. It means that all subsystems of the antioxidant response stay
inactivated. Therefore, after the controller is switched off the network is not ready
to work in the healthy state conditions.
Strategy B
The controller utilizes the same 6 inputs but 2 model outputs. In addition, the
concentration of diseased mitochondria is added as an output, as well as a new
reference signal that corresponds to the concentration of diseased mitochondria in
healthy state (5 nmol/l). In this scenario the controller utilizes more inputs (ROS,
Bcl-xL, Parkin and p62) to control the network (Fig. 4.3 (b1)). It helps to control
both the concentration of the healthy and diseased mitochondria. However, the
network does not demonstrate a proper behavior. After the accumulation of healthy
mitochondria (Fig. 4.3 (b2)) the network suddenly collapses against a background
of a strong oxidative stress (Fig. 4.3 (b3)). Thus, a usage of two model outputs is
still not enough to effectively control the network relaxation process.
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Strategy C
The controller utilizes the same 6 inputs but 3 model outputs. In addition, the
concentration of the ROS is added as an output, as well as a new reference signal
that corresponds to the concentration of the ROS in the healthy state (10 nmol/l).
In this scenario the controller uses almost all available model inputs (Fig. 4.3 (c1))
trying to control three model outputs. Apparently, this control strategy is better
than the previous ones. After 600 hours of simulation the concentrations of the
ROS and diseased mitochondria are close to the target values (Fig. 4.3 (c2) and
(c3)), as well as the concentration of the healthy mitochondria is large enough. If
to compare with the results of uncontrolled relaxation (Fig. 3.16), one can find that
a controlled approach demonstrates a faster dynamics of the network relaxation.
If the controller is not switched off after 600 hours then one can observe the ROS
concentration collapse, since further increasing of Bcl-xL synthesis suppresses the
synthesis of diseased mitochondria, which are essential sources of the ROS. At the
same time the ROS degradation is not affected. The combination of these two
processes gives the decreasing of the ROS concentration.
Conclusion
The strategy of the controlled relaxation of the ROS management network includes
an intensive control of the protein Bcl-xL generation. This provides a quick enough
accumulation of healthy mitochondria. The drawback of the strategy is a slow
accumulation of impaired mitochondria and the ROS. This factor does not allow
to provide a proper functioning of the antioxidant response. The best result of the
controlled network relaxation is achieved when the controller drives three model
outputs (ROS, healthy mitochondria and impaired mitochondria).
4.5.3 Network controllable death
The model of the ROS management network demonstrates a very large basin of
attraction for the stable steady state. Since there is a very little chance to exactly
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calculate the basin (because of a dimension of the system) then it is hardly possible
to define a minimum necessary disturbance that could make the model to leave its
steady state. On the other hand, such situation might be observed in case of a
cancer cell that demonstrates an impressive viability. One possible way to kill a
cancer cell is to cause a strong oxidative stress.
To find the possible ways of killing a cell one may consider the healthy ROS
management network and then to use a controller to switch it to the diseased state
with zero (or about zero) concentration of healthy mitochondria. Indeed, a very
small concentration of healthy mitochondria directly leads to the lack of ATP and,
as a result, to the corresponding negative processes in a cell: a decrease in the
intracellular pH, a start of harmful enzymatic processes, a fragmentation of the
nucleus, a cell death [157].
There are three possible scenarios of the controlled cell death via significant
reduction of the concentration of healthy mitochondria (Fig. 4.4).
Strategy A
The controller can use nine inputs to drive a model. They are the generation rates
of seven proteins Bcl-xL, IKK, Keap1, Nrf2, p62, DJ-1, Parkin, the ROS and an-
tioxidants. As an output the concentration of healthy mitochondria is used. The
reference signal is a constant value corresponding to the zero concentration of healthy
mitochondria. As a result of the simulation the controller utilizes only three model
inputs (Fig. 4.4 (a1)). All other inputs remain are not set in motion by the con-
troller and, hence, are not shown. The effective and rather fast decrease of the
concentration of healthy mitochondria (Fig. 4.4 (a2)) is guaranteed by a sharp in-
crease of the ROS synthesis (up to 20-fold increase that is a maximum value set for
the controller) and simultaneous cut of the generation of AO and Bcl-xL. The cut of
Bcl-xL completely suppresses the mitochondria recovery process. The combination
of above conditions creates a very strong oxidative stress (Fig. 4.4 (a3)) that quickly
kills a cell.
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Figure 4.4: A simulation of the network death via significant reducing
the concentration of healthy mitochondria. In (a)-series the model has nine
controlled inputs for the generation rates: ROS, Bcl-xL, AO, IKK, Keap1,
Nrf2, p62, DJ-1, Parkin. Only three inputs are driven by the controller
during the simulation: ROS, Bcl-xL and AO (a1). The concentration of
healthy mitochondria significantly reduces (a2) against the background of
a very strong oxidative stress (a3). In (b)-series there is no control for the
ROS and AO generation. Only one input for Bcl-xL (b1) is controlled, all
other inputs remains inactive. The time needed for a significant reducing
of the concentration of healthy mitochondria is twice larger than in the (a)-
series. There is no strong oxidative stress. In (c)-series the control of Bcl-
xL generation is switched off. All remaining inputs take part in the control
process (c1). The time for the reducing of the concentration of healthy
mitochondria is increased significantly (b2) against the background of a
strong oxidative stress (c3). The simulation is performed with Simulink.
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Strategy B
In this simulation series the controller can use only seven inputs. It is not able to
regulate the ROS and antioxidant generation anymore. The model output and the
reference signal remain the same. The controller chooses the protein Bcl-xL as a
main player (Fig. 4.4 (b1)), leaving all other inputs inactive. To reduce the concen-
tration of healthy mitochondria the controller cut the mitochondria recovery process
by a suppressing the generation of Bcl-xL. As a result there is no strong oxidative
stress (Fig. 4.4 (b3)). This strategy is not so effective as a previous one and requires
double time to kill a cell (Fig. 4.4 (b2)). The Figure 4.4 (a1) also demonstrates a
feature of using the Simulink controller. When the concentration of healthy mito-
chondria reaches its reference value, the controller increases the generation of the
protein Bcl-xL up to the maximal permitted value and then decreases it again to
zero value. Thus, the controller prevents a further decrease of the concentration into
the region of negative values. Therefore, the appearance of this peak is caused by
the realization of the MPC algorithm. Finally, it means that any strategy proposed
by the controller should be additionally verified to eliminate the artificial dynamics
created by the features of the MPC algorithm realization.
Strategy C
In this simulation series the controller utilizes only 6 inputs. The regulation of the
protein Bcl-xL is switched off. The model output and the reference signal remain
the same. In this case the controller utilizes all remaining inputs to reach the refer-
ence value (Fig. 4.4 (c1)). It suppresses the generation of Parkin and significantly
decreases the generation of p62. This makes mitophagy process slower and leads
to the accumulation of diseased mitochondria and corresponding increasing of the
ROS concentration providing the conditions for the oxidative stress (Fig. 4.4 (b3)).
As well, the controller decreases the generation of DJ-1 violating the antioxidation
response. This strategy is not effective (Fig. 4.4 (c3)). To decrease significantly
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the concentration of healthy mitochondria it takes 10 times more time than the
strategy B does.
Conclusion
According to the obtained results there are two good strategies. The first one is to
increase the ROS synthesis and to decrease the AO and the protein Bcl-xL gener-
ation. This causes an oxidative stress and cut the antioxidant response. Another
way is to suppress the generation of Bcl-xL, thus, significantly reducing the rate
of mitochondria recovery. The latter method allows to save diseased mitochondria
that generate additional ROS and, thus, amplify the oxidative stress.
4.5.4 Protein knockdown and knockout
In a normal situation a cell generates proteins with some rate. In case of disease
or mutation one can observe a downregulation or an upreguation of proteins. As
a result of a downregulation an expression of a protein is reduced (knockdown) or
even completely stopped (knockout). In case of an upregulation the expression of a
protein increases significantly. Both scenarios might have different effects for a cell
functioning. A very good example is a violation of the protein DJ-1 generation. A
downregulation of DJ-1 decreases the antioxidant defense of a cell [158], high ratio
of an inactive form of DJ-1 has been observed in patients with PD and Alzheimer’s
disease [159]. On the other hand, an upregulation of DJ-1 might improve a mito-
chondrial function [160].
In case of a downregulation of DJ-1 a cell experiences either lack of healthy
mitochondria or their complete absence (Fig. 4.5). The latter might mean a cell
death.
In case of the DJ-1 knockdown (the generation rate of the protein decreases
by the factor of two) the concentration of healthy mitochondria decreases almost
twice. The concentration of impaired mitochondria and the ROS increases moder-
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ately (Fig. 4.5 (a,b)). Despite the absence of a strong oxidative stress the network is
in danger. The lack of healthy mitochondria means an insufficient ATP generation.
In case of the DJ-1 knockout (the generation of the protein is stopped completely)
the concentration of healthy mitochondria reaches a zero value. At the same time,
the network experiences a severe oxidative stress. Both factors leave a very small
probability for a cell survival.
Using the MPC controller it is possible to discover the strategies to maintain the
healthy mitochondria concentration in the cases of a downregulation of the DJ-1.
To define possible strategies more accurately the controller measures only one model
output (the concentration of healthy mitochondria) and consequently look through
the different model inputs, analyzing only one input per a simulation.
The DJ-1 knockdown
In case of DJ-1 knockdown the concentration of healthy mitochondria decreases
almost twice. This means that a cell experiences a lack of ATP. The MPC controller
tries to find such dynamics of the controlled input to maintain the concentration of
healthy mitochondria close to the steady state level as long as possible. The results
of the simulation are presented in Fig. 4.6.
The protein Nrf2. A control of Nrf2 (Fig. 4.6 (a)) does not help to maintain
the concentration of healthy mitochondria close to the steady state level. A minor
decrease of the ROS concentration is observed.
The protein Bcl-xL. A usage of Bcl-xL as the model input gives an excellent
result for the concentration of healthy mitochondria (Fig. 4.6 (b)). It is not a
surprise since this protein regulates the process of the mitochondria recovery. The
oscillatory nature of the signal generated by the controller is explained by the fact
that the target concentration should be in the region of the steady state value.
Therefore the concentration of healthy mitochondria also oscillates.
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Figure 4.5: The downregulation of the protein DJ-1 accompanies neu-
rodegenerative diseases. It can have two forms: a knockdown and a knock-
out. The knockdown corresponds to a partial decrease of a protein gener-
ation, the knockout is a full suppression of a protein generation. In case of
the DJ-1 knockout (a double decrease of the generation rate) the concen-
tration of healthy mitochondria significantly decreases (a), whilst the ROS
concentration has a moderate increase (b). When the network experiences
the DJ-1 knockout (the generation is completely cut), the concentration of
healthy mitochondria drops to zero (c) against a background of a strong
oxidative stress (d). The simulation is performed with Simulink.
The antioxidants. It might be expected that the AO control should help a cell to
maintain the healthy mitochondria concentration. However, it only helps with the
decrease of the ROS (Fig. 4.6 (c)). The concentration of diseased mitochondria is
even bigger. Therefore, after the controller stops the AO regulation the accumulated
impaired mitochondria might cause a strong oxidative stress.
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Figure 4.6: The controlled knockdown of the protein DJ-1. Every simula-
tion set (from a to h) corresponds to a controlled generation change of one
of the following species: the proteins Nrf2, Bcl-xL, IKK(Nf-κB), Parkin,
p62, Keap1, the AO and the ROS. The controller uses single model output
(healthy mitochondria) and one model input. In every set 1 – a dynam-
ics of the controlled input calculated by the controller, 2 – a comparison
of the mitochondria dynamics with/without controller, 3 – a comparison
of the ROS dynamics with/without controller. See the next page for a
continuation. The simulation is performed with Simulink.
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Figure 4.6: The controlled knockdown of the protein DJ-1 (cont.).
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The protein IKK. Being the regulator of both Nf-κB and p62 the protein IKK
can regulates simultaneously the processes of the mitophagy and mitochondria re-
covery. This double action should help to control three species: the ROS, healthy
and impaired mitochondria (Fig. 4.6 (d)). Using a set of the pulses that drive the
IKK generation, the controller manages to maintain the concentration of healthy
mitochondria and reduce the overall oxidative stress via a periodical suppression of
the ROS and impaired mitochondria concentrations.
The protein Parkin. Using this model input the controller again demonstrates a
good efficiency that could be comparable with the usage of the protein IKK (Fig. 4.6 (e)).
The only significant difference is the bigger periodic oxidative stress, caused by a
higher amplitude of the oscillation of the ROS concentration.
The protein p62. This control strategy helps to decrease the ROS and impaired
mitochondria concentrations (Fig. 4.6 (f)). However, the healthy mitochondria con-
centration (and, hence, ATP generation) is not changed by the controller.
The protein Keap1. The control of this protein makes the network unbalanced
when the concentrations are changed in a high range (Fig. 4.6 (g)).
ROS. A change of the ROS synthesis can hardly affect the concentration of healthy
mitochondria. Indeed, like the case of the Keap1 control, the network becomes
unstable and experiences a sharp ROS oscillation and the increase of the impaired
mitochondria concentration (Fig. 4.6 (h)).
The DJ-1 knockdown
In case of complete suppression of the DJ-1 generation a cell might quickly die
because of lack of the energy, since the healthy mitochondria concentration goes
to zero. It is hardly possible that any control strategy might prevent a cell death.
However, it might postpone the time when the healthy mitochondria concentration
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reaches zero. The simulation is carrying out within the same conditions as for the
case of the DJ-1 knockdown. The results of the simulation are presented on Fig. 4.7.
Surprisingly, almost any control strategy helps to prolong a cell life. The only ex-
ception is a regulation via Keap1 (Fig. 4.7 (g)) when the ROS management network
loses healthy mitochondria quickly and at the same time experiences a sharp pulse
of oxidative stress. There are three good candidates to maintain the concentration
of healthy mitochondria in the network experiencing DJ-1 knockdown
 The protein Bcl-xL. Using this protein as a controlled input gives good
results for the healthy mitochondria concentration (Fig. 4.7 (b)). The network
lives, at least, 10 times longer than in the case without a participation of the
controller. However, after a short decrease, the ROS concentration quickly
rises. As well, impaired mitochondria concentration gradually increases with
time.
 The protein IKK. This control strategy acts slightly better (Fig. 4.7 (d)).
It demonstrates the comparable results for healthy mitochondria and the ROS
concentrations. The strategy manages to keep a relatively low level of impaired
mitochondria.
 The protein Parkin. This approach demonstrates the best result for all
three species. It manages the concentrations of both healthy and impaired
mitochondria as well as restrains the increase of the ROS during some time.
However, almost all strategies do not manage to deal with an increasing oxidative
stress. Only using the antioxidants allows to contain the ROS concentration below
the level defined by the simulation without the control.
4.6 Model control conclusion
An application of the control theory to the models of biological systems and networks
allows to find control strategies that can demonstrate unusual system’s behavior.
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Figure 4.7: The controlled knockout of the protein DJ-1. Every simula-
tion set (from a to h) corresponds to a controlled generation change of one
of the following species: the proteins Nrf2, Bcl-xL, IKK(Nf-κB), Parkin,
p62, Keap1, the AO and the ROS. The controller uses single model output
(healthy mitochondria) and one model input. In every set 1 – a dynam-
ics of the controlled input calculated by the controller, 2 – a comparison
of the mitochondria dynamics with/without controller, 3 – a comparison
of the ROS dynamics with/without controller. See the next page for a
continuation. The simulation is performed with Simulink.
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Figure 4.7: The controlled knockout of the protein DJ-1 (cont.).
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When starting from a particular initial condition a system chooses a trajectory that
describes its evolution. A usage of the MPC controller allows to create the additional
trajectories that can not be chosen by an uncontrolled system.
An effective usage of the MPC controller requires a proper choice of model inputs
and outputs. By changing the inputs in time the MPC controller tries to provide
the best agreement of model outputs and the reference signals. The reference signal
might either stay constant or change in time.
A practical implementation of an obtained driving signal strongly depends on
its characteristic. In case of biological systems it can correspond to a medicine
injection or any other external impact (radiation, chemical influence) and, therefore,
can hardly contain sharp gradients or quick oscillations.
For the particular problem of the DJ-1 downregulation the MPC approach demon-
strates good results. It generates some strategies for maintaining the healthy mi-
tochondria concentration in case of the DJ-1 knockdown and knockout. The best
results are demonstrated when the controller regulates the proteins Bcl-xL, IKK and
Parkin. These proteins are responsible for the processes of mitophagy and impaired
mitochondria recovery and, in practice, might be targeted using an external impacts
(for Bcl-xL [161, 162], for IKK [163, 164], for Parkin [165, 166]).
A usage of the MPC approach for the analysis of bioregulatory networks might
be a powerful tool, that can provide the suggestions for the treatment and the killing
strategies (cancer research).
Chapter 5
Outlook and perspectives
5.1 Model limitations
The built model is the base one for the description of the functionality of the ROS
management network. As it has been already said it includes several necessary blocks
that provide the links between the mitochondrial dynamics, changing of the ROS
concentration and antioxidant response. However, further usage and development
of the model assume the elimination of several limitations.
ATP
The model does not contain ATP, ADP and water – the essential species that are
directly used for the energy generation in a cell. Hence, the value of ATP concen-
tration might be used for the estimation of the energy potential of a cell, where zero
value of ATP might mean a cell death. At the moment, the concentration of healthy
mitochondria is used as an estimator of a cell well-being. These new elements allow
to consider the processes that take part in the electron transport chain. Another
reason is the fact that a cell might have non-mitochondrial sources of energy [167].
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Translation and transcription processes
To describe a protein generation the model uses an abstract source with an unlimited
capacity and a certain rate constant. In the reality there are two stages: transcrip-
tion (the process of copy of DNA into messenger RNA) and translation (usage of
mRNA to generate a protein). Absence of these stages simplifies the description of a
protein generation but decreases the number of parameters and, hence, complicates
a validation procedure. Indeed, the documented values of a protein transcription
and translation (if any) should be applied with a caution since the reaction of a
protein synthesis is neither a translation reaction nor transcription one.
Protein complexes and oxidation
The model uses three protein complexes (Keap1, Nrf2 and DJ-1) that might be
oxidized. The oxidation process is described via an existence of two forms of a
protein: active and inactive. In reality, a protein oxidation might involve more
stages and states. For example, the oxidation of the DJ-1 includes four stages [159].
Cytochrome c
The cytochrome complex (cyt c) is a protein that associated with the inner mem-
brane of the mitochondrion. It takes part in the transfer of electrons between com-
plexes III and IV of the ETC. This protein is also involved in the initiation of
apoptosis that starts upon release of cytochrome c to the cytoplasm. Accumulation
of the certain concentration of the cytochrome c might be considered as an indicator
of a cell death. In the current model of the ROS management network a cell death
is only connected with loosing the bigger part of the healthy mitochondria.
Other components
Several other species and interactions also might be added to the model: Pink1,
that affects mitochondrial functioning [168, 169] and activates Parkin [170, 171];
the process of both Nrf2 and p62 ubiquitination by Keap1 that marks them for
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a degradation [172]; mRNA layer for the proteins; more detailed layer of NFkB
signalling [173, 174].
5.2 The route to personalized medicine
5.2.1 Detailed model of the ROS management network
Taking into account above-mentioned recommendations, it is possible to build the
detailed model of the ROS management network that can be used to open new
possibilities for the prediction and the explanation of the existing phenomena in the
ROS management network (see Appendix D.1).
The detailed model would have a higher level of complexity than the model V that
would complicate the validation process as well as any concerning computational
task. This work could be done in the frame of a separate project and can take
considerable time. The creation and analysis of the detailed model is an important
step towards to a simulation of the personalizes medicine cases, when the model can
be adapted to a unique case of a particular patient. This approach would allow to
created personalized treatment strategies.
5.2.2 Stress adaptation
A properly working ROS management system should demonstrate the stress adapta-
tion behavior [175], that appears in stabilization of key parameters (the mitochondria
and ROS concentrations) irrespective of the oxidative stress fluctuations. Indeed,
the model V is able to demonstrate such behavior (Fig. 5.1). During this simulation
the model experiences a periodic changes of the ROS synthesis with a maximum
coefficient of amplification of 20. Under these condition the model demonstrates
an interesting phenomena: a homeostatic adaptation to the stress. The healthy
mitochondria concentration reaches the local minimum and then shows the ascend-
ing trend and reaches about 80% level of the initial concentration. The number of
impaired mitochondria becomes even smaller in comparison with no-stress dynam-
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Figure 5.1: The model experiences a periodic stress caused by a har-
monic oscillation of the ROS synthesis (a). Despite of the strong periodic
oxidative stress (c) the model demonstrates good stress adaptation for
both healthy and impaired mitochondria (b). The frequency of the stress
oscillation (about 8 hours between turning points) is chosen to correspond
to a usual daily cycle. The dashed lines show the components steady
state level before the stress application. The simulation is performed with
Simulink.
ics. All these processes occur against a background of a strong oscillatory oxidative
stress. In practice, this process might be compared with an oscillatory oxidative
stress caused by the intracellular calcium oscillations [176] in some specific neuronal
groups affected by PD. This process might be counterbalanced by the excessive
ATP generation [177]. Finally, if the stress conditions last long enough a cell might
die [178, 179].
The model V does not demonstrate the full picture of this phenomenon. It
manages with an oxidative stress but does not show the collapse if the stress re-
mains. The detailed model of the ROS management network with included ATP
generation is expected to demonstrate this feature. Moreover, it would let to check
some strategies to treat this state or, at least, to postpone the system collapse. For
example, recent research has shown the anticorrelation of drinking coffee and PD
development [180]. It is known that the caffeine has a beneficial effect on the Nrf2
dynamics [181]. Hence, the increased generation of Nrf2 in the detailed model might
decrease the oxidative stress and normalize ATP generation.
As well, the detailed model would allow to be consistent with experimental ob-
servations showing how the increased extracellular transport of α-synuclein (corre-
CHAPTER 5. OUTLOOK AND PERSPECTIVES 101
sponds to the increased concentration of α-synuclein in detailed model) may induce
ROS production [182].
5.2.3 Personalized medicine
Above, the system fragility under the stress has been identified. The most probable
explanation is the perturbation in p62 generation. This protein plays the essential
role in the impaired mitochondria management. It is known that the dynamics
of p62 is associated with PD. First, a synthesis of p62 is regulated by DJ-1 that
can be downregulated by PD [183]. Second, p62 may be isolated by alfa-synuclein,
that can be also related to PD [61]. Strictly speaking, these two processes can
be related to a couple of different patients having PD with different mechanisms
of development. And the treatment should not be the same in both cases. This
idea is closely related to the quickly developing area of the personalized medicine
(precision medicine, P4) [184, 185]. The main idea of this approach is to consider
each disease case individually taking into account the features of the particular
patient: DNA, mutations, a disease risk assessment. It has been discovered recently
that the patients can respond differently to the same medicine. For example, about
40% of the patients with asthma, depression and diabetes are non-sensitive to a
standard medicines [186]. The same parameter for cancer and neurodegenerative
diseases can reach the value of 70%.
Another advantage of the personalized medicine is a decrease of adverse drug
reactions (ADR). Many ADRs happen because of the variations in genes concerning
the drug-metabolized enzymes, for example, cytochrome P450 [187]. An application
of the test results for a detection of cytochrome P450 variations can significantly
improve the ADR statistics [188]. Another good example is a management of the
warfarin that is used to prevent the blood clots. Typically, the dosage for an indi-
vidual patient varies by trial and error method. It can be dangerous for the patient
causing either an excessive bleeding or further development of the blood clots. The
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usage of genotyping before the application of warfarine treatment allows to define
the dosage more precisely [189].
To simulate different pathophysiological scenarios for the personalized medicine
the detailed model of the ROS management might be used. The current model V
does not have some essential components to make this kind of simulation (VDAC,
alfa-synuclein).
5.3 Adaptive model predictive control
In the previous chapters it has been shown that the application of the MPC method
allows to develop different strategies for the system control. However, the fact that
the MPC approach uses a linearized model, poses some limitations on its application.
For example, the standard MPC controller can fail when simulating a system with
a strong non-linearity or when system characteristics are changing dramatically in
time. In these cases the adaptive MPC might be used [190]. This approach allows
to adapt a predictive model according to the changing operating conditions. The
simplest realization of the adaptive MPC is a predictive model with evolving in time
parameters.
The application of the adaptive MPC method is a natural development of the
control approach introduced in the current thesis. It allows to take into account a
various stochastic processes that take part in genes expression [191] or when consid-
ering the chemical reactions in a single cell [192].
5.4 Further concept development
The transfer from the model V to the detailed model corresponds to the changes in
the model components and the pathways between them. To get the model onto a
new level more global changes might be introduced as pointed out below.
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Paracellular level
The current model of the ROS management network describes only the intracellular
ROS regulation. The next step would be to consider the ROS management for the
cell population. Thus, some net effects may occurs. There are a number of the
extracellular processes that may play an important role: a proliferation, a differenti-
ation, a mutation, death as well as a transformation from healthy to impaired state.
The ROS concentration can also depend on a cell density.
Extension of the ROS status
The current model is focused on a cell damaging role of the ROS. To consider both
sides of the coin it might be possible to consider also the beneficial function of the
ROS. For example, ROS take part in the immune response, in a regulation of a cell
proliferation, in a management of injuries [193].
Interaction with other cellular processes
The ROS interact with cell cycle via several pathways including, the alteration
of mitochondrial functioning, the oxidation of various proteins, the modulation of
the activity of transcription factors (e.g. Nrf2), the crosstalk with other signalling
molecules (e.g., nitric oxide – NO).
Currently, the crosstalk between ROS and NO is not taken into account. In
reality, they are connected in several ways, e.g., chemical reactions [194] or ROS-
induced modulation [195]. In its turn, NO modulates ROS synthesis, e.g., via the
superoxide release [196]. When produced, nitric oxide modulates the expression of
cell cycle regulatory proteins [197] and, thus, plays one of the central roles in the
modulation the development of cancer [198]. At high concentrations, NO induces
apoptosis and inhibits cancer growth, whereas at physiological concentrations, NO
favors cell proliferation and tumor growth [199]. An appropriate intervening with
NO may be used in a cancer therapy [199, 200]. The incorporation of NO into the
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model of ROS management network could help to understand the contradictory role
of NO and face the model towards cancer research.
Chapter 6
Conclusion
In the current thesis the design principles of the ROS management network were
investigated. They concerned special roles of mitophagy, mitochondrial recovery,
Keap1-Nrf2 complex and the protein DJ-1 in the ROS regulation. These principles
were used for the step-by-step development of the models of ROS management
network with an increasing complexity (“domino” approach). Every subsequent
model was compared to previous one and introduced a new property of the ROS
management. One of the most important conclusions is the fact that the recovery
of impaired mitochondria should be correlated to the change of the intracellular
ROS concentration. “Domino” methodology allowed both to investigate the roles
of different regulatory mechanisms in the ROS management and to justify their
inclusion in the model. As a result, the core model of the ROS management network
was developed. It includes a basic but sufficient number of the ROS regulatory
mechanisms and components.
The parameters of the model of the ROS management network were estimated
using experimental data. To do that the resolution of the core model was increased to
correspond to experimental conditions. The validated model demonstrated two real
and positive steady states: one stable and one unstable. These states can correspond
to a healthy and disease (oxidative stress) state of the regulatory network. It has
been shown that there is a trajectory from disease to healthy state, however it
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requires non-zero values for the concentrations of healthy and disease mitochondria
as well as ROS. It means, for example, that the efficiency of the ROS regulation
significantly decreases if the ROS concentration is too small.
A computer simulation can provide useful information on system dynamics for
different environmental conditions. However, research in the field of biology and
medicine implies not only a passive monitoring but also an active control. To simu-
late different control strategies the model of ROS management network was exported
to Simulink environment where the MPC controller was set up. It has been shown
that there can be different control strategies that allow to maintain the proper ROS
management even in the presence of negative environmental factors. In the current
thesis the cases of knockdown and knockout of the protein DJ-1 were considered. At
the same time the question of controlled system death was investigated. It has been
shown that even a healthy network could be switched to a very diseased state by
means of dynamic control of the network inputs. These strategies can be developed
further in the field of cancer research.
Using a “domino” approach, the developed core model of the ROS managements
system could be augmented with additional modules and subsystems that will allow
to use it for other research. Thus, the concept of a very detailed ROS management
model was proposed. It includes new elements (ATP, CytC, alpha-synuclein, etc.)
and higher resolution for the proteins synthesis and interaction. The detailed model
can be an extremely useful for the simulation of eustress and distress behaviour as
well as to be used for the personalized medicine research.
At present, the developed model does not claim the full description of the ROS
management processes. However, it clearly states how research in the field of neu-
rodegenerative diseases may benefit from design principles studies performed with
the help of dynamic modelling and application of control strategies.
Appendices
107
Appendix A
Models description and
parametrization
A.1 The model II
The model II includes the following variables (Table A.1) and is described by the
ODE system (A.1).

dx1
dt
= Sp11 − p21x1x3,
dx2
dt
= p21x1x3 − p111x2x5x6,
dx3
dt
= Sp31x2 − p61x3x4,
dx4
dt
= −p51x4 + Sp41x9,
dx5
dt
= Sp71 − p81x5 − p111x2x5x6,
dx6
dt
= −p101x6 − p111x2x5x6 + Sp91x9
dx7
dt
= p122 (Skeap1 − x7)− p121x3x7,
dx9
dt
= p132 (Snrf2 − x9)− p131x7x9
(A.1)
The system (A.1) does not include the variables x8 and x10. Since the concentrations
for the total pool of both Keap1 and Nrf2 remain constant, then these variables can
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Variable Reactant St.state,
nmol/l
x1 healthy mitochondria 50
x2 impaired mitochondria 5
x3 ROS 10
x4 antioxidants 200
x5 protein Parkin 50
x6 protein p62 50
x7 protein Keap1 (active) 200
x8 protein Keap1 (inactive) 20
x9 protein Nrf2 (active) 20
x10 protein Nrf2 (inactive) 200
Table A.1: The variables for the model II. The values of the steady state
are obtained after the model parametrization.
be excluded from the ODE system using the substitutions x8 = Skeap1−x7 and x10 =
Skeap1 − x9. The values of the non-kinetic parameters and rate constants included
in the system (A.1) are provided in the Table A.2 and Table A.3 correspondingly.
Non-rate constant Value, nmol/l
Skeap1, total Keap1 concentration 220
Snrf2, total Nrf2 concentration 220
S, abstract source 1
Table A.2: The values of non-kinetic parameters for the model II.
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Rate constant Value
p11, mitochondria synthesis 1.25× 10−3s−1
p21, mitochondria aging 2.5× 10−6s−1
(
nmol
l
)−1
p31, ROS synthesis 4× 10−5s−1
(
nmol
l
)−1
p41, antioxidant synthesis 10
−4s−1
(
nmol
l
)−1
p51, antioxidant degradation 10
−5s−1
p61, ROS degradation 10
−7s−1
(
nmol
l
)−1
p71, Parkin synthesis 1.75× 10−3s−1
p81, Parkin degradation 10
−5s−1
p91, p62 synthesis 8.75× 10−5s−1
(
nmol
l
)−1
p101, p62 degradation 10
−5s−1
p111, mitophagy 10
−7s−1
(
nmol
l
)−2
p121, Keap1 inactivation 10
−4s−1
(
nmol
l
)−1
p122, Keap1 inactivation 10
−2s−1
p131, Nrf2 activation 5× 10−4s−1
(
nmol
l
)−1
p132, Nrf2 activation 10
−2s−1
Table A.3: The values of rate constants for the model II.
A.2 The model III
The model III includes the following variables (Table A.4) and is described by the
ODE system (A.2). The system (A.2) does not include the variables x8 and x10.
Since the concentrations for the total pool of both Keap1 and Nrf2 remain constant,
then these variables might be excluded from the ODE system using the substitutions
x8 = Skeap1 − x7 and x10 = Skeap1 − x9. The values of the non-kinetic parameters
and rate constants included in the system (A.2) are provided in the Table A.6 and
Table A.5 correspondingly.
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Variable Reactant St.state,
nmol/l
x1 healthy mitochondria 50
x2 impaired mitochondria 5
x3 ROS 10
x4 antioxidants 200
x5 protein Parkin 50
x6 protein p62 50
x7 protein Keap1 (active) 200
x8 protein Keap1 (inactive) 20
x9 protein Nrf2 (active) 20
x10 protein Nrf2 (inactive) 200
x11 protein Nf-κB 100
x12 protein Bcl-xL 100
Table A.4: The variables for the model III. The values of the steady
state are obtained after the model parametrization.

dx1
dt
= Sp11 − p21x1x3 + p181x2x12,
dx2
dt
= p21x1x3 − p111x2x5x6 − p181x2x12,
dx3
dt
= Sp31x2 − p61x3x4,
dx4
dt
= −p51x4 + Sp41x9,
dx5
dt
= Sp71 − p81x5 − p111x2x5x6,
dx6
dt
= −p101x6 − p111x2x5x6 + Sp91x9x11
dx7
dt
= p122 (Skeap1 − x7)− p121x3x7,
dx9
dt
= p132 (Snrf2 − x9)− p131x7x9,
dx11
dt
= Sp141x5 − p151x11,
dx12
dt
= Sp161x11 − p171x12
(A.2)
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Rate constant Value
p11, mitochondria synthesis 1.25× 10−3s−1
p21, mitochondria aging 2.5× 10−6s−1
(
nmol
l
)−1
p31, ROS synthesis 4× 10−5s−1
(
nmol
l
)−1
p41, antioxidant synthesis 10
−4s−1
(
nmol
l
)−1
p51, antioxidant degradation 10
−5s−1
p61, ROS degradation 10
−7s−1
(
nmol
l
)−1
p71, Parkin synthesis 1.75× 10−3s−1
p81, Parkin degradation 10
−5s−1
p91, p62 synthesis 8.75× 10−5s−1
(
nmol
l
)−2
p101, p62 degradation 10
−5s−1
p111, mitophagy 10
−7s−1
(
nmol
l
)−2
p121, Keap1 inactivation 10
−4s−1
(
nmol
l
)−1
p122, Keap1 activation 10
−2s−1
p131, Nrf2 inactivation 5× 10−4s−1
(
nmol
l
)−1
p132, Nrf2 activation 10
−2s−1
p141, Nf-κB synthesis 2× 10−5s−1
(
nmol
l
)−1
p151, Nf-κB degradation 10
−5s−1
p161, Bcl-xL synthesis 10
−5s−1
(
nmol
l
)−1
p171, Bcl-xL degradation 10
−5s−1
p181, Bcl-xL mitochondrial repair 9.75× 10−5s−1
(
nmol
l
)−1
Table A.5: The values of rate constants for the model III
Non-rate constant Value, nmol/l
Skeap1, total Keap1 concentration 220
Snrf2, total Nrf2 concentration 220
S, abstract source 1
Table A.6: The values of non-kinetic parameters for the model III.
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Variable Reactant St.state,
nmol/l
x1 healthy mitochondria 50
x2 impaired mitochondria 5
x3 ROS 10
x4 antioxidants 200
x5 protein Parkin 50
x6 protein p62 50
x7 protein Keap1 (active) 200
x8 protein Keap1 (inactive) 20
x9 protein Nrf2 (active) 20
x10 protein Nrf2 (inactive) 200
x11 protein Nf-κB 100
x12 protein Bcl-xL 100
x13 protein DJ-1 (active) 20
x14 protein DJ-1 (inactive) 200
Table A.7: The variables for the model IV. The values of the steady
state are obtained after the model parametrization.
A.3 The model IV
The model IV includes the following variables (Table A.7) and is described by the
ODE system (A.3). The system (A.3) does not include the variables x8 and x10.
Since the concentrations for the total pool of the proteins Keap1, Nrf2 and DJ-1
remain constant, then these variables might be excluded from the ODE system using
the substitutions x8 = Skeap1−x7, x10 = Skeap1−x9 and x14 = Sdj1−x13. The values
of the non-kinetic parameters and rate constants included in the system (A.3) are
provided in the Table A.8 and Table A.9 correspondingly.
APPENDIX A. MODELS DESCRIPTION AND PARAMETRIZATION 114
dx1
dt
= Sp11 − p21x1x3 + p181x2x12,
dx2
dt
= p21x1x3 − p111x2x5x6 − p181x2x12,
dx3
dt
= Sp31x2 − p61x3x4,
dx4
dt
= −p51x4 + Sp41x9,
dx5
dt
= Sp71 − p81x5 − p111x2x5x6,
dx6
dt
= −p101x6 − p111x2x5x6 + Sp91x9x11
dx7
dt
= p122 (Skeap1 − x7)− p121x3x7,
dx9
dt
= p132 (Snrf2 − x9)− p131x7x9
p133 + x13
,
dx11
dt
= Sp141x5 − p152x11
p151 + x13
,
dx12
dt
= Sp161x11 − p171x12,
dx13
dt
= −p201x13 + p191x3 (Sdj1 − x13)
(A.3)
Non-rate constant Value, nmol/l
Skeap1, total Keap1 concentration 220
Snrf2, total Nrf2 concentration 220
Sdj1, total DJ-1 concentration 220
S, abstract source 1
p133, Nrf2 activation 5
p151, NF-κB degradation 10
Table A.8: The values of non-kinetic parameters for the model IV.
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Rate constant Value
p11, mitochondria synthesis 1.25× 10−3s−1
p21, mitochondria aging 2.5× 10−6s−1
(
nmol
l
)−1
p31, ROS synthesis 4× 10−5s−1
(
nmol
l
)−1
p41, antioxidant synthesis 10
−4s−1
(
nmol
l
)−1
p51, antioxidant degradation 10
−5s−1
p61, ROS degradation 10
−7s−1
(
nmol
l
)−1
p71, Parkin synthesis 1.75× 10−3s−1
p81, Parkin degradation 10
−5s−1
p91, p62 synthesis 8.75× 10−5s−1
(
nmol
l
)−2
p101, p62 degradation 10
−5s−1
p111, mitophagy 10
−7s−1
(
nmol
l
)−2
p121, Keap1 inactivation 10
−4s−1
(
nmol
l
)−1
p122, Keap1 activation 10
−2s−1
p131, Nrf2 inactivation 5× 10−4s−1
p132, Nrf2 activation 10
−2s−1
p141, Nf-κB synthesis 2× 10−5s−1
(
nmol
l
)−1
p152, Nf-κB degradation 10
−5s−1
p161, Bcl-xL synthesis 10
−5s−1
(
nmol
l
)−1
p171, Bcl-xL degradation 10
−5s−1
p181, Bcl-xL mitochondrial repair 9.75× 10−5s−1
(
nmol
l
)−1
p191, DJ-1 activation 10
−4s−1
(
nmol
l
)−1
p201, DJ-1 inactivation 10
−2s−1
Table A.9: The values of rate constants for the model IV
Appendix B
Model validation and analysis
B.1 Model structure
To perform the procedure of parameters estimation, using the experimental data
provided by University of Maastricht, the following changes are introduced into the
base model IV.
 The mitochondrial recovery reaction is combined together with the reaction of
mitochondrial aging. Instead, the protein Bcl-xL becomes an inhibitor of the
reaction of mitochondrial aging.
 The simple reaction of healthy mitochondria synthesis is replaced by more
realistic mechanism where the existing healthy mitochondria are used as a
substrate for new mitochondria [201]. The mechanism uses Michaelis-Menten
kinetics to avoid uncontrolled increase of the concentration of healthy mito-
chondria.
 Synthesis and degradation reactions are added for the proteins Keap1, Nrf2,
DJ-1. It allows to use experimental data to check the results of parameter
estimation procedure.
 The subsystem of menadione injection is added to the model. According to
the experiment injected menadione is transformed into the internal form that
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Figure B.1: The model V of the ROS management network that is
validated using experimental data provided by University of Maastricht.
The non-kinetic parameters (p133) and (p151) allow to avoid an infinite
inhibition in the case of zero concentration of the protein DJ-1.
activates the ROS production inside a cell. At the same time the menadion
degrades itself [202, 203].
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Variable Reactant St.state,
nmol/l
x1 healthy mitochondria 50
x2 impaired mitochondria 5
x3 ROS 10
x4 antioxidants 200
x5 protein Parkin 50
x6 protein p62 50
x7 protein Keap1 (active) 200
x8 protein Keap1 (inactive) 20
x9 protein Nrf2 (active) 20
x10 protein Nrf2 (inactive) 200
x11 protein Nf-κB 100
x12 protein Bcl-xL 100
x13 protein DJ-1 (active) 20
x14 protein DJ-1 (inactive) 200
x15 menadion 10
5
x16 menadion (internal) 0
Table B.1: The variables for the model V. The values of the steady
state are obtained after the estimation of the model parameters using
experimental data. To make simulation without menadion the variable
x15 should be equal to zero.
B.2 Model parameters
The model V includes the following variables (Table B.1) and is described by the
ODE system (B.1). The values of the non-kinetic parameters and rate constants
included in the system (B.1) are provided in the Table B.2 and Table B.3 corre-
spondingly.
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
dx1
dt
=
Sp11x1
p12 + x1
− p21x1x3
x12
,
dx2
dt
= −p111x2x5x6 + p21x1x3
x12
,
dx3
dt
= Sp31x2 − p61x3x4 + p32x16,
dx4
dt
= −p51x4 + Sp41x9,
dx5
dt
= Sp71 − p81x5 − p111x2x5x6,
dx6
dt
= −p101x6 − p111x2x5x6 + Sp91x9x11,
dx7
dt
= Sp201 − p211x7 − p121x3x7 + p122x8,
dx8
dt
= p121x3x7 − p122x8 − p271x8,
dx9
dt
= p132x10 − p131x7x9
p133 + x13
,
dx10
dt
= Sp221 − p132x10 − p251x10 + p131x7x9
p133 + x13
,
dx11
dt
= Sp141x5 − p152x11
p151 + x13
,
dx12
dt
= Sp161x11 − p171x12,
dx13
dt
= −p191x13 − p281x13 + p181x3x14,
dx14
dt
= Sp241 + p191x13 − p261x14 − p181x3x14,
dx15
dt
= −p231x15 + p232x16,
dx16
dt
= p231x15 − p232x16 − p291x16
(B.1)
Non-rate constant Value, nmol/l
p12, mitochondria generation 1
p133, Nrf2 activation 1
p151, NF-κB degradation 1
S, abstract source 1
Table B.2: The values of non-kinetic parameters for the model V.
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The values of model V parameters show a good correspondence to the ranges,
defined in the Table 2.1. However, one might notice different time scales for mito-
chondrial dynamics. The rate constants for the mitophagy and mitochondria aging
are inside the previously defined range, but the rate constant for the mitochondrial
synthesis is not. The possible explanation here is the fact that the time range for
mitochondrial dynamics is defined from the value of mitochondrial turnover, the
process that includes many stages, which might have different timescales. In this
case the mitochondria synthesis might be a relatively fast process that is followed by
slower processes of mitochondrial aging and mitophagy. So the total mitochondria
turnover is found out to be a slow process.
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Rate constant Value, s−1
p11, mitochondria synthesis 10
−5s−1
p21, mitochondria aging 1.96× 10−6s−1
p31, ROS synthesis (1) 10
−4s−1
(
nmol
l
)−1
p32, ROS synthesis (2) 10
−5s−1
p41, antioxidant synthesis 10
−4s−1
(
nmol
l
)−1
p51, antioxidant degradation 10
−5s−1
p61, ROS degradation 2.5× 10−7s−1
(
nmol
l
)−1
p71, Parkin synthesis 10
−3s−1
p81, Parkin degradation 1.98× 10−5s−1
p91, p62 synthesis 1.25× 10−6
p101, p62 degradation 5× 10−5s−1
p111, mitophagy 7.8× 10−10s−1
(
nmol
l
)−2
p121, Keap1 inactivation (1) 10
−4s−1
(
nmol
l
)−1
p122, Keap1 inactivation (2) 10
−2s−1
p131, Nrf2 inactivation (1) 1.05× 10−5s−1
p132, Nrf2 inactivation (2) 10
−5s−1
p141, Nf-κB synthesis 3.6× 10−7s−1
(
nmol
l
)−1
p152, Nf-κB degradation 3.8× 10−6s−1
(
nmol
l
)
p161, Bcl-xL synthesis 7× 10−6s−1
(
nmol
l
)−1
p171, Bcl-xL degradation 7× 10−6s−1
p181, DJ-1 activation 10
−5s−1
(
nmol
l
)−1
p191, DJ-1 inactivation 10
−3s−1
p201, Keap1 synthesis 5.06× 10−3s−1
p211, Keap1 degradation (act) 2.3× 10−5s−1
p221, Nrf2 synthesis 2.4× 10−3s−1
p231, Menadion activation (1) 2.6× 10−3s−1
p232, Menadion activation (2) 0.29s
−1
p241, DJ-1 synthesis 3.3× 10−3s−1
p251, Nrf2 degradation 1.2× 10−5s−1
p261, DJ-1 degradation (in) 1.5× 10−6s−1
p271, Keap1 degradation (in) 2.3× 10−5s−1
p281, DJ-1 degradation (act) 1.5× 10−6s−1
p291, Menadion degradation 2.9× 10−3s−1
Table B.3: The values of rate constants for the model V
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B.3 Steady state calculation
To find the steady states of the model of the ROS management network it is neces-
sary to solve the following system of algebraic equations:
p11x1
p12 + x1
− p21x1x3
x12
= 0,
− p111x2x5x6 + p21x1x3
x12
= 0,
p31x2 − p61x3x4 + p32x16 = 0,
− p51x4 + p41x9 = 0,
p71 − p81x5 − p111x2x5x6 = 0,
− p101x6 −−p111x2x5x6 + p91x9x11 = 0,
p201 − p211x7 − p121x3x7 + p122x8 = 0,
p121x3x7 − p122p61 − p271x8 = 0,
p132x10 − p131x7x9
p133 + x13
= 0,
p221 − p132x10 − p251x10 + p131x7x9
p133 + x13
= 0,
p141x5 − p152x11
p151 + x13
= 0,
p161x11 − p171x12 = 0,
− p191x13 − p281x13 + p181x3x14 = 0,
p241 + p191x13 − p261x14 − p181x3x14 = 0,
− p231x15 + p232x16 = 0,
p231x15 − p232x16 − p291x16 = 0
(B.2)
Using an elimination method numerous analytical solutions can be obtained.
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Solution 1 
x1 = 0,
x2 = 0,
x3 = 0,
x4 = 0,
x5 =
p71
p81
,
x6 = 0,
p201 − p211x7 − p121x3x7 + p122x8 = 0,
p121x3x7 − p122p61 − p271x8 = 0,
p132
p221
p251
= 0,
x10 =
p221
p251
,
p141x5 − p152x11
p151 + x13
= 0,
p161x11 − p171x12 = 0,
− p191x13 − p281x13 + p181x3x14 = 0,
p241 + p191x13 − p261x14 − p181x3x14 = 0,
x15 = 0,
x16 = 0
(B.3)
The solution (B.3) is unfinished since it leads to an undetermined system of
equations [204]. At the same time, in order to get p132
p221
p251
= 0 either p132 or p221
should have a zero value. This scenario can correspond to the case of a reaction
suppression and might require a separate investigation.
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Solution 2 
x1 = 0,
x2 = 0,
x3 = 0,
x4 =
p41p71p91p132p133p141p151p211p221
p51p81p101p131p152p201p251
,
x5 =
p71
p81
,
x6 =
p71p91p132p133p141p151p211p221
p81p101p131p152p201p251
,
x7 =
p201
p211
,
x8 = 0,
x9 =
p132p133p211p221
p131p201p251
,
x10 =
p221
p251
,
x11 =
p71p141p151
p81p152
,
x12 =
p71p141p151p161
p81p152p171
,
x13 = 0,
x14 =
p241
p261
,
x15 = 0,
x16 = 0
(B.4)
This solution always exists. Any combination of rate constants gives non-negative
and real values for the steady state.
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Solution 3 
x1 = 0,
x5 = 0,
p31x2 − p61x3x4 + p32x16 = 0,
− p51x4 + p41x9 = 0,
p71 = 0,
− p101x6 −−p111x2x5x6 + p91x9x11 = 0,
p201 − p211x7 − p121x3x7 + p122x8 = 0,
p121x3x7 − p122p61 − p271x8 = 0,
p132
p221
p251
− p131x7x9
p133 + x13
= 0,
x10 =
p221
p251
,
p161x11 − p171x12 = 0,
− p191x13 − p281x13 + p181x3x14 = 0,
p241 + p191x13 − p261x14 − p181x3x14 = 0,
x15 = 0,
x16 = 0
(B.5)
The solution (B.5) is unfinished since a requirement p71 = 0 appears that leads to
an undetermined system of equations. This scenario can correspond to the case of
a reaction suppression and might require a separate investigation.
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Solution 4 
x1 = 0,
x6 = 0,
p31x2 − p61x3x4 + p32x16 = 0,
− p51x4 + p41x9 = 0,
x5 =
p71
p81
,
x11 = 0,
p201 − p211x7 − p121x3x7 + p122x8 = 0,
p121x3x7 − p122p61 − p271x8 = 0,
p132
p221
p251
− p131x7x9
p133 + x13
= 0,
x10 =
p221
p251
,
p141
p71
p81
= 0,
p171x12 = 0,
− p191x13 − p281x13 + p181x3x14 = 0,
p241 + p191x13 − p261x14 − p181x3x14 = 0,
x15 = 0,
x16 = 0
(B.6)
The solution (B.6) is unfinished since a requirement p141
p71
p81
= 0 appears that leads
to an undetermined system of equations. This scenario can correspond to the case
of a reaction suppression and might require a separate investigation.
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Solution 5
x1 =
−p12p21x3 + p11 p161p171
−f6(x3)±
(
p141p151f5(x3)
p111p152f4(x3)
+
p141p181f1(x3)f5(x3)x3
p111p152f4(x3)
)
2(p91p141p151f3(x3)−p81p152+p91p141p181f1(x3)f3(x3)x3)
p21x3
,
−p9p111
p81 + p111x6(x3)
f4(x3)x6(x3) +
p11x1(x3)
p12 + x1(x3)
= 0,
x3 = f4(x3),
x4 =
p41
p51
f3(x3),
x5 = p71
(
p81 + p111f4(x3)
−p81p101p152 + p9p111p152f4(x3)− f5(x3)
2p101p111p152f4(x3)
)−1
,
x6 =
−p81p101p152 + p9p111p152f4(x3)− f5(x3)
2p101p111p152f4(x3)
,
x7 = (p122 + p271)f2(x3),
x8 = p121f2(x3)x3,
x9 = f3(x3),
x10 =
p221
p251
,
x11 =
−f6(x3)±
(
p141p151f5(x3)
p111p152f4(x3)
+ p141p181f1(x3)f5(x3)x3
p111p152f4(x3)
)
2 (p91p141p151f3(x3)− p81p152 + p91p141p181f1(x3)f3(x3)x3) ,
x12 =
p161
p171
−f6(x3)±
(
p141p151f5(x3)
p111p152f4(x3)
+ p141p181f1(x3)f5(x3)x3
p111p152f4(x3)
)
2 (p91p141p151f3(x3)− p81p152 + p91p141p181f1(x3)f3(x3)x3) ,
x13 = p181f1(x3)x3,
x14 = f1(x3)(p191 + p281)
x15 = 0,
x16 = 0
(B.7)
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where
f1(x3) =
p241
p191p261 + p261p281 + p181p281x3
,
f2(x3) =
p201
p122p211 + p211p271 + p121p271x3
,
f3(x3) =
p132p221 (p133 + p181f1(x3)x3)
p131p251 (p122 + p271)
,
f4(x3) =
p41p61
p31p51
f3(x3)x3,
f5(x3) =
[
(p71p111p152f4(x3)− p81p101p152)2 +
+ 4p71p91p101p111p141p152f3(x3)f4(x3) (p151 + p181f1(x3)x3)]
1/2 ,
f6(x3) = p9p141p151 + p9p141p181f1(x3) +
p81p101p141
p111f4(x3)
(p151 + p181f1(x3)x3) .
(B.8)
The main idea of this solution is to chose some key variable and express all other
variables of the system as a function of it. In the case of the system (B.8) the key
variable is x3. Finally, only one equation for x3 left in the system. Depending on
its order, the equation might be solved either analytically or numerically. After
obtaining the solutions for x3 all other variables values can be easily calculated.
Solution analysis
Finally, the system (B.2) has only two reasonable solutions (B.4) and (B.7). If
to use the values of rate constants from the Tables B.2 and B.3 and to reject the
solutions containing complex numbers, then the real steady state solutions can be
found (Table B.4). The Solution 5b should be rejected since it contains negative
values that makes no sense for the concentration values.
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Model variable Solution 2,
nmol/l
Solution 5a,
nmol/l
Solution 5b,
nmol/l
Healthy mitochondria, x1 0 50 -1
Impaired mitochondria, x2 0 5 6.8 × 104
Reactive oxygen species, x3 0 10 1200
Antioxidants, x4 8.61 200 2.3 × 104
Parkin, x5 50.5 50 -0.12
p62, x6 0.1 50 -155
Keap1, active form, x7 220 200 17
Keap1, inactive form, x8 0 20 203
Nrf2, active form, x9 0.9 20 2292
Nrf2, inactive from, x10 200 200 200
Nf-κB, x11 4.8 100 -2.36
Bcl-xL, x12 4.8 100 -2.36
DJ-1, active form, x13 0 20 203
DJ-1, inactive form, x14 220 200 17
Menadion (external), x15 0 0 0
Menadion (internal), x16 0 0 0
Table B.4: The real steady states solutions for the validated model V.
Appendix C
Creation of the MPC controller in
Simulink
Simulink is a graphical environment that uses a principle of visual programming.
A user can utilize provided blocks to create a model and to perform an analysis
and a simulation. The main advantage of Simulink is an ability to perform com-
plex calculations just with a few clicks. Appearance of blocks used in Simulink is
sometimes very similar to the designations of the different elements of electrical cir-
cuits. However, the models created in Simulink have nothing common with electrical
circuits.
To demonstrate the basic principles of building a model in Simulink as well as a
MPC controller one may consider a simple differential equation:
dx
dt
= −ax, (C.1)
where a is a positive constant.
The solution of (C.1) is well-known and represented by an exponential decay
x = e−at. To solve this equation in Simulink one should built a simple model
(see Fig. C.1).
After applying the ODE solver in Simulink one could obtain the solution (see
Fig. C.2).
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Figure C.1: The simulink model for the differential equation (C.1). The
block “Int” performs an integration to obtain the solution signal x(t), the
block “Mult” performs a multiplication of x(t) with the constant value
−a.
The equation (C.1) might be sophisticated by an addition of a temporal depen-
dence for the parameter a:
dx
dt
= −a(t)x. (C.2)
For the simplicity the parameter a(t) might be considered as a signal generator
that switches between 0 and 1 with a frequency of 2Hz. In the current example
the exact form of a(t) is unimportant. However, a stepwise generator might be con-
sidered as a simulator of periodical environmental changes (daily injections, regular
exposure to a stress, etc.). The Simulink model for this case is presented in Fig. C.3.
Figure C.2: The solution given by Simulink for the equation (C.1). As
it was expected the solution is a damping exponent x = e−at.
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Figure C.3: Simulink model for the equation (C.2). Instead of the con-
stant a there is a pulse generator. For simultaneous displaying of two
signals (the solution x(t) and the generator signal a(t)) the multiplexer
“Mux” is used.
For the current equation it is impossible to obtain a fully analytical solution
since the generator provides a discrete signal. However, one can assume that for
those time points when a = 1 the solution will match the one of (C.1). If the
generator gives 0 then the right part of (C.2) becomes also 0 and the solution is just
a constant (see Fig. C.4).
As a final example the following non-trivial case is considered. One can take
again the equation (C.2) and assume that there is a certain known solution x¯(t).
The question is how the signal a(t) should be changed to satisfy the equation
dx¯
dt
= −a(t)x¯. (C.3)
Figure C.4: The solution given by Simulink for the equation (C.2). The
final solution is a mix of a damping exponent and the constant values.
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Figure C.5: Simulink model for the equation (C.3). The reference signal
x¯(t) is e−at where a is the random number with a mean value 0 and a
variance 0.1. The MPC controller should generate the driving signal a(t)
to minimize the difference between x(t) and x¯(t).
This problem could be solved with the MPC method. Indeed, the equation (C.3)
may be considered as a model of some process, x¯(t) is a reference signal, a(t) is a
model input (or a driving signal coming from the MPC controller) and finally x(t) is
an output signal of the model generated under the control a(t). To make the problem
less trivial a random noise is introduced into the reference signal x¯(t) (see Fig. C.5).
As a result, Simulink provides the driving signal to solve this optimal control prob-
lem (see Fig. C.6).
Figure C.6: The solution that is given by Simulink for the equation (C.3).
A red line is the reference signal x¯(t), which includes random jumps, orange
line is a controller output signal a(t) which is used to make a model output
signal (black line) as close as possible to the reference signal.
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As one can see the MPC controller manages to find the driving signal that
provides a satisfactory correspondence of the model output and the reference signal.
Despite the factor of a random noise, the output signal manages to repeat trends of
the reference signal. The result becomes more valuable if take into account that the
controller has no idea about future dynamics of the reference signal because of the
random component. The controller has to adapt constantly its output to follow the
reference signal.
Strictly speaking, an introduction of the randomness into the reference signal
increases the complexity of this problem. And the most appropriate way to find
a solution is to use the theory of robust MPC. Nevertheless, even using of simple
MPC controller provides good enough results.
Simulink provides the great possibilities for the simulation of the ODE systems.
Once a model is built, one can perform an enormous amount of numerical experi-
ments. For example, different types of generators could be used to present a peri-
odical consumption of medicines or to present environmental changes of a constant,
a periodical or a random nature. A usage of the MPC controller allows predicting
the possible ways to change a model state that might be correspond to the seeking
of the treatment strategies. Rich capabilities for signal measurements and routing
allow to obtain the value of any variable (or set of variables) at the any point of a
model. This simplifies the analysis of a model and helps to find the errors if any.
Appendix D
Detailed model of the ROS
management network
The detailed model of the ROS management system (Figure D.1) is a natural de-
velopment of the model V. Several new components and reactions are added.
 The protein Pink1 that protects a cell from the damage caused by a mitochon-
drial dysfunction.
 ATP, ADP and water – the essential species that are directly used for the
energy generation in a cell.
 More detailed description of translation and transcription processes.
 The cytochrome complex that is involved in the initiation of apoptosis.
 The process of both Nrf2 and p62 ubiquitination by Keap1.
 More detailed layer of NF-κB signalling.
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Figure D.1: The detailed model of the ROS management network that
is considered as an improvement of the model V. The model is built with
COPASI and CellDesigner [205].
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